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Abstract:

Nova-1 is a neuron-specific RNA binding protein, distributed both in the nucleus and

the cytoplasm of several populations of neurons. The work presented here confirms th

Nova-1 binds a sequence of RNA found in an intron of the glycine receptor a2 subunit

pre-mRNA. Evidence that Nova-1 acts as a regulator of alternative splicing in transf

cell lines is presented. Furthermore, a direct role of Nova-1 on splicing is demonst

by establishing an in vitro assay for Nova-l's regulatory role in splicing. Potentia

functional partners of Nova are suggested by the demonstration of physical interacti

between Nova-1 and molecules whose action in the splicing machinery is well describe
such as Ul 70K, a protein component of UlsnRNP, and U2AF65.

The sedimentation properties of Nova in neuronal cytoplasmic extracts are consistent
with the engagement of Nova in heterogeneous structures, probably mRNPs, and with
polysomes, suggesting a role for Nova in the regulation of cytoplasmic phenomena of
RNA metabolism, such as mRNA localization and translation. These considerations

prompted a gene expression screen aimed to identify differences in the pool of mRNAs
associated with heavy polysomes in wild type and Nova-1-null mice. Several genes
whose mRNAs have been found to undergo changes in abundance specifically in the

polysome fraction in the absence of Nova have described functional roles in post-syn

terminal structure and functions. Nova-1 was also found to be a phospho-protein, and
phosphorylation site is in an alternative cassette exon.

C h a p t e r

1

AN INTEGRATED VIEW OF GENE EXPRESSION

The journey of RNA from transcription to translation into protein has traditionally

been described as a series of discrete steps that happen in well-defined compartment
the cell. Upon the completion of transcription, the pre-mRNA, coated by hnRNPs,
undergoes capping of the 5' end, splicing of the intronic sequences, cleavage and
polyadenylation in the nucleus; the mature mRNA is then exported in the cytoplasm,

where it is translated and eventually decays. This view of gene expression as a succ

of discrete steps was suggested by the ability of in vitro assays to re-capitulate m
these events in isolation and by the non-overlapping localization in the nucleus of

transcription and sites containing splicing factors. While the view of a highly stru

and functionally compartmentalized cell and nucleus is still valid (Carmo-Fonseca, 2

Spector, 2001), studies performed during the last decade are delineating a rather mor

integrated picture of the mechanisms of gene expression. Furthermore, it is becoming
apparent that some RNA binding proteins are capable of playing more than one

functional role in different compartments of the cell. The early post-transcriptiona

of capping, splicing and poly-adenylation seem to all take place on RNAs which are s

undergoing transcription or still engaged in the transcription machinery. I will bri
review some evidence of such integration, focusing on the splicing events.

1) Transcription and p r e - m R N A splicing:
The idea that pre-mRNA splicing happens co-transcriptionally dates back to almost

twenty years ago, when Fakan et al. suggested such relationship based on the localiz

of a subset of snRNPs in Perichromatin Fibrils, structures known to be enriched in n
synthesized pre-mRNAs (Fakan et al., 1984; Fakan et al., 1986). Furthermore, RNAs

apparently undergoing splicing while still being transcribed were directly visualize
Beyer and Osheim by electron microscopy on chromatin spreads (Beyer and Osheim,
1988; Osheim and Beyer, 1991). In the following years, a number of lines of evidence

to the current model, according to which pre-mRNAs are spliced co-transcriptionally,
while Interchromatin Granule Clusters and Cajal bodies are highly dynamic storage

and/or reassembly sites for SR proteins and snRNP, respectively, (Zhang et al., 1994)
reviewed in Huang and Spector, 1997).
The influence of the transcriptional promoter on the subsequent steps of RNA
processing was first suggested by the observation that RNA polymerase II (RNAP II)

genes expressed under the control of RNA polymerase III promoters were not processed

properly (Sisodia et al., 1987). Subsequently, different RNAP II promoters, driving t

transcription of the same a-globin/fibronectin reporter minigene, were shown to affe

the splicing of an alternative exon (Cramer et al., 1999; Cramer et al., 1997). The a

of promoters to affect cassette exon utilization seems to correlate with their abili

influence RNAP II processivity, defined as the ability to elongate through sites whe

polymerase is prone to pause or premature termination (Kadener et al., 2001; Kadener
al., 2002). Two not mutually exclusive models have been proposed to account for the

observed effects of transcriptional enhancers, promoters and activators on alternati

splicing. According to one model, promoters would have differential ability to recruit

different sets of splicing factors, which would then be able to differentially splic

RNAs. The alternative model proposes that the effect of promoters on splicing is due

their ability to provoke the commitment of more or less processive RNAP II. In the c

of one alternatively included cassette exon, low RNAP II processivity and internal p

would favor the presentation of the upstream, alternative 3'splice site to the spli

apparatus before the downstream constitutive 3' splice site has been synthesized, th

favoring the exon-including product (Caceres and Kornblihtt, 2002). The kinetic model

has been directly verified in recent studies, in which the processivity of RNAP II w
decreased pharmacologically or by inserting pause elements downstream of the
alternative exon (Nogues et al., 2002; Roberts et al., 1998).
The integration between RNA processing events described so far involve
upstream events (like transcription) affecting downstream events (like splicing). A
recent studies shows that RNA processing factors can feed back, in turn influencing
transcription rate. In vitro studies show that TFIIH contains stochiometric amounts
snRNA, and that depletion of U1 snRNA makes the TFIIH less efficient in "abortive

initiation" and re-initiation assays (Kwek et al., 2002). Consistent with this findin

promoter-proximal 5' splice site, recognized by Ul snRNA, stimulates the rate of TFI

dependent re-initiation in vitro and the overall rate of transcription in vivo (Furg
2002; Kwek et al., 2002). Furthermore, the TAT-SF1 transcription factor was found to
form a complex with U snRNPs, and to stimulate transcriptional elongation. The
stimulation was more efficient when functional splice sites were present in the
transcribed product (Fong and Zhou, 2001). These recent findings are beginning to

provide a mechanistic explanation for the increased efficiency of transcription of

transgenes with artificial introns near the 5' end, observed more than ten years ago
(Brinster et al., 1988; Palmiter et al., 1991).

2) Molecular Aspects of Transcription-RNA Processing integration:
Interestingly, RNAP II itself has been identified as a component of the pre-mRNA

splicing machinery. The largest subunit of RNA polymerase II is characterized by the
presence of an unusual carboxy-terminal domain (CTD), rich in potential phospho-

acceptor aminoacid residues, comprised of a heptapeptide with the consensus Tyr-SerPro-Thr-Ser-Pro-Ser tandemly repeated fifty two times (in human). The
hypophosphorylated form of the RNApol II (RNAP II A) is associated with the pre-

initiation complex, while the hyperphosphorylated form (RNAP II O) is associated wit
transcription elongation complexes that have cleared the promoter area (reviewed in
(Howe, 2002)

RNAP IIO was found to be specifically associated with functional splicing complexes,

and a dramatic inhibition of pre-mRNA splicing (and 3'processing) was observed in c
in which the only active form of RNAP II had a CTD truncation (McCracken et al.,

1997b; Mortillaro et al., 1996). In a similar experimental setting, the recruitment o

and U2 snRNP to the transcription sites was shown to be impaired (Misteli and Specto
1999). These experiments suggest that the hyperphosphorylated CTD of RNAP II

increases the local concentration of splicing factors, among which are SR proteins a
SCAFs (SR-like CTD-associated factors), in proximity of the emerging transcript
(Mortillaro et al., 1996; Misteli and Spector, 1999; (Yuryev et al., 1996). A direct

R N A P II in promoting splicing independent of its function in transcription was also
demonstrated. In an in vitro splicing assay employing pre-transcribed substrates,
phosphorylated RNAP II was shown to promote the assembly of an early splicing
complex, whereas the unphosphorylated isoform of RNAP II was shown to have the
opposite effect (Hirose et al., 1999).

The integration of transcription and splicing is only one aspect of a complex web o

interactions that takes place in the nucleus during the early phases of RNA processi
The pre-RNA processing events of capping, splicing, and polyadenylation have been

shown in recent studies to affect each other, and the hyperphosphorylated form of th

CTD of RNAP II provides a platform for a number of biochemical interactions involve

in the transcription and RNA processing events and their coupling (McCracken et al.

1997a), reviewed in (Hirose and Manley, 2000; Hirose et al., 1999; Maniatis and Reed,
2002; Proudfoot et al., 2002). Time course experiments have shown that RNA

polymerases and RNA processing factors localize in large, discrete nuclear structure

Cajal Bodies, upon their entry in the nucleus right after translation. Since no tran

or processing take place in the Cajal Bodies, these structures are currently interpr

the assembly place of the large transcription-processing holoenzyme indicated as th

transcriptosome (Gall, 2001; Gall et al., 1999). According to a recent model, from th

Cajal Bodies, RNAP II and processing factors would then reach the transcription site

where clusters of more than one polymerase would assemble into large "transcription

factories", probably anchored to nucleo-skeletal structures (Cook, 1999; Iborra et a
1996; Maniatis and Reed, 2002).

3) m R N A export is coupled with p r e - m R N A splicing:
The field of mRNA export has seen striking progress in the past few years. Nucleo-

cytoplasmic transport of protein and non-coding RNAs is largely mediated by transpor

receptors related (albeit often distantly) to Importing, moving their cargo (or comp
adapter and cargo) across the Nuclear Pore complex (NPC) along a gradient of RanGTP

(Gorlich and Kutay, 1999). In only few instances has the export of mRNA been shown t

fit this general paradigm. One such instance is the well characterized export of uns
HIV genomic RNA. One intron in the unspliced HIV-1 RNAs contains the Rev Response
Element (RRE), which is a binding site for several Rev adaptor molecules. The export
the RNA-Rev protein complex requires a nine aminoacid motif, characterized by four
critically spaced Leucines, called Nuclear Export Signal (NES) (Malim et al., 1989).
NES motif has been found in several other proteins undergoing nucleo-cytoplasmic
export, and has been shown to be required for the interaction with CRM1, an export

receptor belonging to the importing family (Cullen, 2000; Fischer et al., 1995). Simi
messages containing A rich elements (ARE) in their 3'UTR were shown to be exported
through a CRM1-dependent pathway: the protein HuR binds the ARE of these mRNAs,

and it interacts, in turn, with two NES-containing proteins, APRIL and pp32 (Brennan

al., 2000). Furthermore, a parallel HuR-transportin2-dependent pathway for the export
ARE-containing mRNAs was also discovered (Gallouzi and Steitz, 2001).
Unlike these few examples, though, the export of the bulk mRNA from nucleus to

cytoplasm seems to follow a different route, as it is largely not affected by treatm

Leptomycin B, a specific inhibitor of CRM1 (Fornerod et al., 1997; Wolff et al., 1997

In particular, recent studies have elucidated a strict coupling between export and premRNA splicing. Experiments performed in Xenopus oocytes have shown that RNA

resulting from splicing of precursors containing introns injected in the nucleus we

exported with much higher efficiency than RNAs not containing introns. Despite the f

that RNAs resulting from splicing and intronless RNAs were identical in sequence, th

were shown to be complexed with a different set of proteins, presumably recruited by
splicing machinery (Luo and Reed, 1999). This finding opened the hunt for the

characterization of the splicing-dependent protein complex. In a series of elegant i
studies, a protein complex (called EJC: Exon Junction Complex) was shown to form
twenty nucleotides upstream from the exon-exon junction following splicing, and to
remain on the mRNA in the cytoplasm (Kataoka et al., 2000; Le Hir et al., 2000a; Le

et al., 2000b). The identification of some of the components of the complex, and gene

studies performed in yeast, led to the contemporary model of mRNA export. The splici
factor UAP56, a DEAD helicase originally discovered as a U2AF65 co-factor, was
shown to recruit the protein adaptor Aly to the mRNA during the splicing reaction
(Fleckner et al., 1997; Luo et al., 2001; Strasser and Hurt, 2001; Zhang and Green,

Zhou et al., 2000). Aly/REF (and the yeast ortholog Yra 1) is bound, in turn, by the

export receptor TAP (and the yeast ortholog Mex67), a protein that associates with t

nuclear pore (Bachi et al., 2000; Segref et al., 1997). Studies in yeast indicate tha
(Mex67) and UAP56 (Sub2, in yeast) interact with the same region of Aly (Yral)
(Strasser and Hurt, 2001). Therefore, according to the current model, the splicing
machinery would recruit Aly to the mRNP through UAP56 during the splicing reaction.

Aly could even be recruited co-transcriptionally, by interaction with the transcrip
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elongation factors of the T H O complex (Strasser et al., 2002). Subsequently, T A P

displaces UAP56 from its interaction with Aly and leads the mRNP to the nuclear pore
for export (reviewed in (Maniatis and Reed, 2002; Reed and Hurt, 2002).

4) Possible alternative routes of mRNA export in Metazoa:
The model based on the function of EJC, Aly and TAP, which emerged mostly from

studies in yeast, may not entirely account for the complexity of RNA export in metaz

cells. In a recent study, RNAi was used in Drosophila cells to ablate various compon
of the EJC separately and in combination. Interestingly, while TAP and UAP56 were
shown to be required for export of the bulk of mRNA, even the simultaneous ablation
Aly, RNPS1, Y14 and Srml60 that is, all the known components of the EJC did not
result in complete abolition of mRNA export, although a quite substantial nuclear

accumulation of poly(A)+ RNA was observed (Gatfield and Izaurralde, 2002). This resul

raises the possibility that other essential adaptor proteins link UAP56 and TAP in h

eukaryotes, or other export receptors or parallel pathways exist. Consistent with th
hypothesis, a number of RNA binding proteins have been implicated in the export of
specific sets of messages. The heterogeneous nuclear ribonucleoproteins (hnRNP), a

large family of around 20 proteins, are thought to bind nascent RNA during transcrip

and to remain associated with nuclear mRNAs after splicing is completed (Nakielny an
Dreyfuss, 1999). Certain hnRNPs, like hnRNP Al and hnRNPK, have been shown to

shuttle between nucleus and cytoplasm, while others, like hnRNPC, are found exclusiv
in the nucleus (Pinol-Roma and Dreyfuss, 1991; Pinol-Roma and Dreyfuss, 1992). The
shuttling hnRNPs were the first group of proteins implicated in mRNA export for a

variety of reasons. They bind m R N A in both compartments (Pinol-Roma and Dreyfuss,
1992); their export is mediated by NES elements, which are not part of their RNA
binding domain (Michael et al., 1995); excess of hnRNP Al, or of its M9 shuttling
domain, specifically blocks export of dihydrofolate reductase (DHFR) mRNA (Gallouzi
and Steitz, 2001; Izaurralde et al., 1997); an Al-like hnRNP is associated with

translocating Balbiani ring transcripts from the transcription site to the cytoplasm

passing through the NPC (Daneholt, 1997); and yeast strains mutant in Npl3p, a shuttl
hnRNP, show nuclear mRNA accumulation (Lee et al., 1996). Therefore, it seems

probable that hnRNPs play a role in the export of some mRNAs, but the details of the
mechanism of this action and the features of the messages that undergo such mode of
transport are not defined.
Another class of RNA binding proteins that may play a role in RNA export is the

SR family of proteins. A subset of SR proteins have been shown to shuttle between th

nucleus and the cytoplasm (Caceres et al., 1998). Moreover, SR proteins bind exclusiv
to exon sequences in pre-mRNA and remain bound to the exons after the mRNA is
spliced (Graveley, 2000). Two shuttling SR proteins, SRp20 and 9G8 have been
demonstrated to promote the nucleocytoplasmic export of intronless mRNA encoding
histone H2A (Huang and Steitz, 2001). Furthermore, SRp20 and 9G8 can be UV-crosslinked to polyadenylated RNA in the nucleus and the cytoplasm, suggesting that they

could affect some as yet unidentified step of RNA metabolism after the export from t
nucleus (Huang and Steitz, 2001).
The coupling of splicing and export has been interpreted as an RNA proofreading
mechanism. The mRNA, bearing protein coding information, represents a small
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percentage of the total p r e - m R N A transcript: the average size of an exon is 140
nucleotides while the size of introns can be in the thousands and tens of thousands

nucleotides. The splicing apparatus marks the final products of processing with a di

set of proteins: the removed introns coated with a subset of hnRNPs, are prevented f
exiting the nucleus and targeted to degradation, while the mRNA, complexed with
adaptor proteins, export receptors, EJC proteins, and also some hnRNPs, is targeted
export and translation (reviewed in (Reed and Magni, 2001).

5) Nonsense mediated decay (NMD):

Interestingly, Nonsense mediated decay (NMD), another level of control of the quality
the exported message, has been found to be strictly coupled to the EJC deposited in

course of the nuclear processing of RNA. NMD occurs when translation terminates more

than 50-55 nucleotides upstream of the 3'-most exon-exon junction. The EJC, which l

20-24 nucleotides upstream of the exon-exon junction, recruits Upf3/3X, a predominan
nuclear protein that remains on the mRNP upon export to the cytoplasm, where it
interacts with the predominantly perinuclear protein Upf2 (Kim et al., 2001; Lykke-

Andersen et al., 2000; Lykke-Andersen et al., 2001). It is thought that, in the absenc
premature termination codons, the ribosomes would remove the EJC from the mRNA
during the first round of translation. If a nonsense mutation occurs more than 50

nucleotides upstream from the exon-exon junction (which is considered to be the dist
between the decoding site and the leading edge of the ribosome), the ribosome

disassembles and the EJC remains in place. Upf 2 and Upf3/3X are then able to recrui

Upfl, a group 1 helicase, and the other components of the degradation pathway (Sun e
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al., 1998). The notion of a first "pioneering" round of translation, during which
ribosomes scan the message for the presence of premature stop codons, was suggested
a recent study in which NMD was shown to take place in messages associated with
nuclear cap binding protein CBC80, but not in actively translated mRNAs associated
with the eIF4E (Ishigaki et al., 2001). Nonetheless, some important aspects remain

unexplained, like the cellular compartment in which NMD takes place in the cell. Whi

the requirement for scanning of the messages by ribosomes had suggested that NMD is
cytoplasmic phenomenon, fractionation studies have shown that most of the messages
containing premature stop codons undergo NMD in the nucleus or in a functionally

defined nucleus-associated compartment, which is thought to identify the set of mess

in the process of exiting the nucleus but not released yet in the cytoplasm (review
(Hentze and Kulozik, 1999; Maquat and Carmichael, 2001; Schell et al., 2002).
Nonsense-associated altered splicing (NAS) is a putative correction response that

upregulates alternatively spliced transcripts that skip premature termination codon

(Cartegni et al., 2002; Maquat, 2002). This phenomenon and recent evidence suggesting
translation of proteins in the nucleus (Iborra et al., 2001) suggest that scanning
coding sequence of the message could take place in the nucleus (Wilkinson and Shyu,
2002).

6) From the nucleus to the cytoplasm: role of nuclear RNA binding proteins in
translation:

In prokaryotes, which lack subcellular compartments, translation is directly coupled

transcription. In nucleated cells it is generally accepted that molecular tags, such
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components of the exon junction complex, are loaded on transcripts as a result of nuclear
RNA processing events and that these ultimately affect cytoplasmic RNA metabolism.
Nonetheless, in only a few instances has the same RNA binding protein been shown to
affect regulation of the same RNA in the two intracellular compartments. While this
apparent incongruence probably results from the fact that a genome-wide search for
target sequences has been undertaken only for a handful of RNA binding proteins, it

remains possible that RNA binding proteins associate with not completely overlapping
sets of RNAs in the nucleus and in the cytoplasm.
In lower organisms, some RNA binding proteins have been shown to regulate

expression of a single RNA both in the nucleus and in the cytoplasm (Gebauer et al.,

1997). The RNA binding protein Sex Lethal (Sxl) in Drosophila offers one of the most
striking examples of such a mode of regulation. In addition to its role in sex

determination through regulation of alternative splicing (reviewed in the next secti

Sxl regulates dosage compensation by inhibiting the expression of msl-2 at the post-

transcriptional level in the female fly. In the nucleus, the presence of Sxl inhibit
splicing of a small intron in the 5' UTR of msl-2 in female flies. The retention of
intron in the 5'UTR is not in itself sufficient to inhibit the expression of msl-2,

provides a binding site for Sxl in the mature msl-2 transcript. In the cytoplasm Sxl
inhibits the translation of msl-2 by binding the unspliced intron in the 5'UTR and
site in the 3'UTR (Bashaw and Baker, 1997; Gebauer et al., 1998). In a similar way,

Saccharomyces cerevisiae ribosomal protein L32 regulates its own expression at the l
of both splicing and translation (Dabeva and Warner, 1993).
In vertebrates, there has been no description of an RNA binding protein that
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regulates a single R N A in both the nucleus and the cytoplasm. Nonetheless, two R N A

binding proteins structurally similar to Sxl, Polypyrimidine Tract Binding protein (
and hnRNP A2 have been shown to play roles in both splicing and translation. PTB is

well-described splicing factor, and was found associated with many picornavirus IRES
elements; depletion/reconstitution experiments demonstrated that PTB stimulates
translation (Kaminski et al., 1995; Kaminski and Jackson, 1998; Niepmann, 1996). The
mechanisms used by PTB to enhance IRES-dependent translation are presently unknown.

Although a role for PTB in the translation of cellular mRNAs has only been demonstra
in two instances (Kim et al., 2000; Pickering et al., 2003), the presence of IRES and
binding sites in the 5' untranslated region of a variety of cellular mRNAs suggests

observations made in viruses may mirror a more widespread mechanism of translational
control (reviewed in (Valcarcel and Gebauer, 1997). Furthermore, VgRBP60, a Xenopus
laevis homolog of PTB, has been suggested to be involved in the localization of Vgl

the vegetal cytoplasm of the oocyte (Cote et al., 1999). HnRNP A2 is 68% identical at

amino-acid level to hnRNP Al, a well characterized alternative splicing regulator, a

has itself a described ability to modulate alternative splicing (Bilodeau et al., 20

Mayeda et al., 1994). In the cytoplasm of oligodendrocytes hnRNP A2 has been shown t
interact with the mRNA of Myelin Basic Protein (MBP) forming large mRNPs
transported along the cytoskeleton to the myelin compartment (Carson et al., 2001).
Interestingly, the A2 response motif, a short purine rich sequence in the 3' UTR of

mRNA, has been demonstrated to act as a cap-dependent translational enhancer, the fi
such regulatory features described in a mammalian RNA (Kwon et al., 1999). The
Chironomus tentans homolog of the closely related hnRNP Al, which has been mostly
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characterized as a splicing regulator, has been shown to follow the Balbiani ring (BR)
RNA from the nucleus to the cytoplasm, where it remains bound to the mRNA engaged
in actively translating giant polysomes (Visa et al., 1996). A further example of a
and cytoplasmic RNA binding protein whose functional role has been characterized in

both compartments is offered by the strictly related hnRNP K, El and E2. HnRNP K has
recently been suggested to play a role in the regulation of alternative splicing of
tropomyosin pre-mRNA (Expert-Bezancon et al., 2002). HnRNP K binds an intronic

pyrimidine-rich element thirty-seven nucleotides downstream of the 5' splice site of
regulated exon; the presence of the intronic enhancer correlates with increased

recruitment of Ul snRNP (Expert-Bezancon et al., 2002). In the cytoplasm, hnRNP K, El

and E2 are well-characterized regulators of translation and stability of specific me
they inhibit the initiation of translation of the 15-Lipoxygenase mRNA by binding a
pyrimidine-rich repeated sequence in the 3'UTR of the message, and affecting the

assembly of the two ribosomal subunits (Ostareck et al., 2001; Ostareck et al., 1997)
Furthermore, hnRNP Es (also called aCPs or PCBPs) are known to stabilize a-globin

mRNA during erythroid differentiation by interacting with C-rich 3'UTR determinants
(Makeyev and Liebhaber, 2002). Therefore, the ultimate outcome of the interaction of

hnRNP E with the 3'UTR of the 15-lipoxygenase mRNA is reduced translation, while th
interaction with the a-globin mRNA results in enhanced protein synthesis.

A L T E R N A T I V E S P L I C I N G A N D T R A N S L A T I O N A L C O N T R O L IN T H E
NERVOUS SYSTEM
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T h e astonishing complexity of the architecture of the neural system and the variety of
its cell subtypes with unique connectivity patterns have suggested the need for this tissue
to utilize mechanisms that expand proteome complexity. Alternative splicing and RNA
editing are known to play important roles in expanding the repertoire of final protein
products of individual genes, while two other mechanisms responsible for the generation
of the diversity of immunoglobulin and T-cell receptors, genomic re-arrangement or
somatic hypermutation, have not at present been described in the nervous system.
Functional characteristics pose specific requirements on mechanisms of gene
expression in the nervous system. The transmission of neuronal stimuli occurs in
specialized synaptic structures that can be up to several hundred microns away from the
neuronal cell body. Furthermore, studies by electrophysiology have shown that
phenomena of synaptic plasticity can take place in dendritic terminations that have been
severed from the cell bodies, indicating a remarkable functional autonomy of the synapse.
In particular, a now substantial body of work has illustrated the role of translation of
localized messages in the synapse in different aspects of synaptic plasticity. In the
following section I will review some aspects of alternative splicing and translational
regulation of gene expression in the nervous system.

1) Specific aspects of translational control in neurons:
Dendrites are extended and intricate structures, forming thousands of synapses
that can lay hundreds of micrometers far from the cell body. Synapses are plastic
structures, able to change their functional characteristics in response to activity. Since
several experimental paradigms of synaptic plasticity require protein synthesis, the
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distance from the cell body could pose a problem to the cell that has to provide the
synapses with new proteins. The discovery that virtually all the components of the

translational apparatus can be found in the post-synaptic specializations of dendrit
suggested that translation of new proteins could actually happen locally, providing
mechanism for swift changes of concentration of proteins in response to stimulation
(Gardiol et al., 1999; Steward and Levy, 1982). Furthermore, the local synthesis of

proteins at the synapse circumvents the need of targeting proteins newly synthesized
the cell body to the activated synapse, offering a possible mechanistic explanation

documented restriction of enduring functional modification to the stimulated synapse
(reviewed in (Steward and Schuman, 2001). In the twenty years following the initial

finding of ribosomes in the dendrites, several groups have pursued the identificatio
mRNA localized in the dendrites. There are currently about a dozen mRNAs that are

universally recognized as localized in the dendrites, but it is commonly believed th
many more have not been identified yet (Steward and Schuman, 2001). Notably, several

identified mRNAs localized in dendrites encode for proteins for which a role in syna
plasticity has been demonstrated: CaMKIIa mRNA, which encodes for the cc-subunit of

CaMKII, a kinase required for the establishment of both Long Term Potentiation (LTP)
and Long Term Depression (LTD), NRI, encoding a subunit of the TV-methyl-D-aspartate
receptor (NMDAR), Arc, BDNF, and TrkB (Steward and Schuman, 2001). Dendritic

translation has been described both as a consequence of synaptic plasticity and as a

necessary condition for synaptic plasticity. Synaptoneurosomal preparations have bee
stimulated in various ways to show increase of translation of FMRP and CaMKII asubunit by pulse labeling techniques (Bagni et al., 2000; Leski and Steward, 1996;
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Scheetz et al., 2000). Furthermore, stimulation with B D N F results in the increased

dendritic translation of a reporter message containing the GFP coding sequence prec
and followed by the 5' and 3' untranslated regions of a CaMK II mRNA in intact

neurons and in dendrites severed from cell bodies (Aakalu et al., 2001). Reciprocall

hippocampal slices, synaptic potentiation induced by BDNF is blocked by inhibitors o

protein synthesis, also in severed dendrites, demonstrating the requirement of local
translation for synaptic potentiation (Kang and Schuman, 1996). LTD induced through

metabotropic glutamate receptor stimulation has also been demonstrated to depend on

protein synthesis in isolated dendrites (Huber et al., 2000) In a culture preparati

Aplysia sensory and motor neurons, a branch-specific form of long-term facilitation,

induced by repeated application of serotonin, has been shown to be protein synthesis

dependent (Casadio et al., 1999; Martin et al., 1997). More recently, the localizatio
CaMK II mRNA in the dendrites was impaired by modifying the 3' UTR by homologous

recombination in mice (Miller et al., 2002). The absence of localized synthesis of a
CaMK II showed reduced late-phase long term potentiation, and various behavioral
defects (Miller et al., 2002).

2) Proposed mechanisms of translational regulation in dendrites:
Two main modes of regulation of translation in dendrites have been described.
Synaptic stimulation induces the transcription of immediate early genes, which are

specifically transported to the stimulated synapse and translated. Alternatively, m

are constitutively present at the synapse, and the stimulation activates their trans

The first mode of regulation has been best characterized for the gene Arc, which en
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a cytoskeleton-associated synaptic protein that is required for the maintenance of L T P in
the hippocampus (Guzowski et al., 2000). Patterned synaptic activation using a
stimulation paradigm that is commonly used to induce LTP, both induced Arc

transcription and caused the newly synthesized mRNA to localize selectively to acti

synapses (Steward et al., 1998). An increase of Arc protein in the stimulated dendrit
domains was also observed, suggesting that the events of mRNA localization and its
translation are coupled in response to synaptic stimulation (Steward et al., 1998;
and Worley, 2001).

In other instances, the mRNA seems to be constitutively localized in the post-synapt

areas, and synaptic stimulation activates its translation. Several not exclusive mec

have been invoked for the coupling of synaptic stimulation and activation of transla

The inhibition by rapamycin of long term facilitation in Aplysia neurons, and of LTP
hippocampal neurons, suggest a role of the protein kinase target of rapamycin (TOR)

the regulation of synaptic translation (Casadio et al., 1999; Tang et al., 2002). TOR

promotes translation through two pathways: it stimulates initiation of translation b
phosphorylating the eI4E binding protein (4EBP), which, in the hypophosphorylated

state, sequesters the initiation factor 4E. Furthermore, TOR activates p70 S6 kinase

which, in turn, phosphorylates the ribosomal protein S6, and facilitates the transla
mRNAs containing a 5' terminal oligopyrimidine tract (5' TOP), a group of RNAs that
encode several factors involved in translation (reviewed in (Raught et al., 2001).
Besides general activation of cap-dependent translation through activation of TOR,

other mechanisms have been proposed for activation of specific mRNAs in response to
synaptic stimulation. NMDAR stimulation has been shown to rapidly increase a CaM II
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synthesis, while reducing overall translation in synaptoneurosomes from rat superior
colliculus (Scheetz et al., 2000). The increase of a CaM II synthesis is accompanied
phosphorylation of eukaryotic elongation factor 2 (eEF2), a modification known to
reduce the elongation rate. A similar stimulation of a CaM II synthesis is obtained

treatment with cyclohexamide, a drug that inhibits the elongation step of translatio

has been speculated that, when the elongation step of translation becomes rate-limit
the translation of messages that are abundant, but usually inefficiently initiated,
CaM II, are up-regulated (Scheetz et al., 2000).
Cytoplasmic polyadenylation has also been proposed as a possible mechanism for the

regulation of dendritic translation. This mechanism was first characterized in Xenop
oocytes: a number of maternally transcribed mRNAs contain a very short poly(A) tail
are kept untranslated until fertilization. Upon fertilization, the inhibition of
polyadenylation and translation exerted by the cytoplasmic polyadenylation element

binding protein (CPEB) is removed by activation of the Aurora protein kinase, a long

poly(A) tail is synthesized, which is bound by Poly(A) Binding Protein (PABP), which

in turn, recruits eI4F complex, promoting initiation of translation (reviewed in (Me
and Richter, 2001). It has been shown that the a CaM II mRNA contain two CPE in its

3'UTR and that these two elements are functional in repressing translation when a C

II is micro-injected in oocytes (Wu et al., 1998). Furthermore, other components of t

cytoplasmic polyadenylation apparatus are present in dendrites of hippocampal neuro

and increased length of the poly-A tail of a CaM II was observed in response to vis

experience (Wu et al, 1998). These findings were further explored in cultivated neuro
where stimulation of NMDAR receptors was shown to induce translation of a reporter
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under the control of a C a M II C P E (Huang et al., 2002; Wells et al., 2001). A recent
study shows that CPEBP also facilitates the transport of a CaM II mRNA in the

dendrites, presumably in a dormant state, since maskin, the protein involved in tran
repression of CPE-containing messages, is also part of the mRNP complex. Neurons
lacking CPEB or expressing a mutated form of the protein show slower and decreased
transport of the substrate mRNAs (Huang et al., 2003).
The local synthesis of proteins requires the translocation of the mRNAs encoding

them from the cell body to the synapses, either in response to stimulation, as in th
of Arc, or constitutively, as in the case of a CaM KII (Ouyang et al., 1999). The
trafficking of mRNA to sites of translation involves the recognition of cis-acting
sequences, frequently in the 3'UTR, by trans-acting proteins. These messenger
ribonudeoprotein (mRNP) complexes bind to cytoskeletal elements, which drive their

transport and localization. The physical nature of the mRNPs is debated. The existen

extremely large RNA "granules" has been proposed based on studies in cultured primar

neurons (Krichevsky and Kosik, 2001). These structures sediment faster than the larg
polyribosomes on linear density gradients and seem to contain messenger RNAs,

ribosomes and RNA binding proteins. Depolarization of neurons provokes redistributio

of some mRNAs from the granules to the actively translating polysomes (Krichevsky a
Kosik, 2001; Krichevsky and Kosik, 2002). Other studies have proposed that the mRNP

structures devoted to transport and storage of mRNAs are rather heterogeneous in siz
but smaller than the polyribosomes (Feng et al., 1997; Khandjian et al., 1996).
It has been postulated that through the recognition of shared cis-acting sequences
discrete sub-populations of RNAs, RNA-binding proteins can post-transcriptionally
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regulate the expression of functionally related genes (Keene and Tenenbaum, 2002). It is
conceivable that, in the neurons, specific sets of RNA binding proteins may target
mRNPs to specific synapses and confer translational regulation in response to
stimulation.

3) Alternative splicing as a mean to generate proteome complexity:
The contemporary view of genome complexity is remarkably different than what
was anticipated ten years ago, when numbers of genes higher than 105 were commonly

estimated. With a number of genes probably not much higher than thirty thousand, onl
around twice the number of genes of the Drosophila genome (according to December

2002 estimations (Waterston et al., 2002), the mammalian genome has to account for th

startling complexity of higher vertebrates. One probably important source of complex

of the vertebrate proteome is the presence of vertebrate-specific protein domains a

motifs (7% of the total), and the arrangement of pre-existing domains in a more vari
repertoire of architectures (Lander et al., 2001). The richer set of protein domains

suggests a higher potential for regulation at the level of interactions among prote

pathways. Other mechanisms often invoked to explain the complexity of vertebrates ar
pre-mRNA editing and post-translational protein modifications (Banks et al., 2000;
Keeganetal., 2001).
Alternative splicing offers an obvious mechanism through which an organism can
expand the proteome from a limited number of genes, by combining exons in multiple
different ways. While some general principles governing alternative splicing and

examples of remarkably complex patterns of alternative usage of exons have been kno
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for more than a decade, only in the past two years has a systematic appreciation of the
quantitative significance of this mode of gene expression begun to emerge. The
completion of the human and murine genome drafts and the progress of the expressed
sequence tag (EST) project and the RIKEN Mouse Gene Encyclopedia Project allow for

the first time to compare cDNA sequences to the entire genome (Gregory et al., 2002;
McPherson et al., 2001; Okazaki et al., 2002; Venter et al., 2001). Several groups
undertook comparisons between ESTs derived from the same gene, followed by
assessment of the candidate splice sites by alignment of the ESTs to the genomic

sequence of the gene (reviewed in (Modrek and Lee, 2002). They estimated an alternati
splicing frequency ranging between 35 and 59% of the human genes. These estimations
were confirmed by a large international effort to compare 60,770 full-length cDNA

sequences to the newly released draft of the mouse genome (Okazaki et al., 2002). Thi
study estimated a 41% frequency of alternative splicing, in good agreement with the

recent EST-based studies (Modrek et al., 2001). These studies also agree on a high r

(more than 70%) of alternative splicing events affecting the coding sequence (Modrek
al., 2001). While the quantitative impact of alternative splicing on gene expression
appears indisputable, its role in expanding the proteome in vertebrates relative to

organisms is still debated. A survey of the frequency of alternative splicing across

different organisms shows no appreciable difference between vertebrate and invertebr

(Brett et al., 2002). However, due to the incomplete coverage of the EST database in
some of the organisms analyzed, the authors of this study were forced to compare a
limited set of cDNAs, leaving out cDNAs with more complex patterns of alternative

splicing. It is possible that once the comparison of all the cDNAs becomes possible,
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differences across species may emerge (discussed in (Maniatis and Tasic, 2002).

4) Alternative splicing and the Nervous System:
A recent analysis of the public databases shows that 10-30% of human alternatively

spliced genes show a tissue-specific pattern of exon utilization (Xu et al., 2002). T

tissue with the largest total number of tissue-specific splice form was brain, which
represented 18% of all the observed tissue-specific alternative splicing events (Xu

2002). This is consistent with results of previous studies that had shown that nervo

immune system account for the highest frequency of alternative splicing (Modrek et a

2001; Stamm et al., 2000). These studies provide the first quantitative support to th

concept that the Central Nervous System (CNS) utilizes alternative splicing as a mea

increase the complexity of its proteome, and, therefore, its ability to give rise to
different cell subtypes and innumerable synaptic connections, an idea that has been
popular for a number of years (Darnell, 1998; Grabowski, 1998).
The concept that the CNS needs a very large repertoire of different molecules

derives intuitively from the large number of neurons (estimated to be roughly 1010),

vast variety of neuronal subtypes and the high number of specific synaptic connectio
among them (up to 105 in a single Purkinje neuron). Sixty years ago, Roger Sperry's

seminal experiments provided the first evidence that axon guidance and establishment

synaptic connections are governed by chemospecificity, or by specific sets of molecu

guiding axons to their targets. It is currently widely believed that the diversity o
subtypes and the complexity of their synaptic connections reflect differential gene
expression that confers each neuron's morphology, position, connectivity and
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physiological characteristics. For example, motor neurons of the spinal cord have been

shown to be grouped in multiple pools, each characterized by the expression of a uni
combination of transcription factors and signaling molecules, with different muscle

targets and afferent connections (reviewed in (Jessell, 2000). Another striking examp
neuronal molecular diversity is the olfactory system, where each olfactory neuron

expresses only one of over 1000 odorant receptor genes, and the receptor defines the
neuron's connection in the brain (Mombaerts et al., 1996).

Consistent with a suggested role of alternative splicing in expanding the ability of

CNS to establish specific intercellular contacts and communications, Modrek et al. s
that 29% of the messages undergoing tissue-specific alternative splicing encode

membrane-anchored receptors, integral membrane proteins and proteins involved in cel

surface adhesion (Modrek et al., 2001). It is indeed among genes involved in adhesion

and axonal guidance that the most complex patterns of alternative splicing have been
described. Dscam, a Drosophila homologue of human Down Syndrome cell adhesion

molecule expressed in the axon processes, can potentially give rise to as many as 38

isoforms, by alternative splicing of four clusters of tandemly arranged exons (Schmu

et al., 2000). Nearly 3,000 neurexins, a group of neuronal cell surface receptors pr

to have a key role in synaptic formation, are predicted to arise by alternative spli

from 6 primary transcripts, deriving from three genes with two alternative transcrip

initiation sites each (Missler and Sudhof, 1998). It has been proposed that the diver

neurexins might be a component of a code that specifies neural connectivity (Missler

al., 1998). Interestingly, the alternative splicing pattern of neurexin is much simpl
Drosophila than in vertebrate (Tabuchi and Sudhof, 2002), suggesting that the much
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higher number of neurexin isoforms may have evolved to match the more complex

architecture of the vertebrate neural system. The family of the a, p\ y protocadheri

(Pcdh) is another source of neuronal protein diversity. The organization of the Pcdh

genes is reminiscent of Immunoglobulin and T cell receptor loci, with clusters of 14
tandemly arranged alternative exons encoding the variable extracellular domain, and

constitutively spliced exons encoding the intracellular constant part. A separate pr

precedes each variable exon. Cis-splicing and, to a minor extent, trans-splicing, ha

shown to take place between the variable and the constant exons, and the differentia

promoter choice is proposed to determine the usage of the 5'-most variable exon (Ta
al., 2002; Wu and Maniatis, 2000; Wu et al., 2001).

5) Mechanisms of Alternative Splicing:
The fundamental step in alternative splicing, as in constitutive splicing, is

discrimination of the part of the pre-mRNA that will be utilized in the message (exo
from the part that will be excised and eventually degraded in the nucleus (intron).

definition of exon-intron boundaries is dictated by the interaction of ds-elements a

i*ran.y-acting factors. The information content of the primary sequence is rather li

the splice sites consensus sequences are short and degenerate in metazoans. The spli

reaction occurs in the spliceosome, a complex molecular machinery constituted by the
five small nuclear Ribonudeoprotein Particles (snRNP Ul, U2, U4, U5, U6), and more
than 60 non-snRNP proteins (Will and Luhrmann, 2001). The early steps of splicing

involve the recognition of the 5' splice site by Ul snRNP, the binding of SF1 to the
branch point, and of U2AF65 and 35 to the polypyrimidine tract and the AG at the 3'
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splice site, respectively. Subsequently, U 2 s n R N P interacts with the branch point, and
U4,U5,U6 enter the complex giving rise to the catalytically active spliceosome (reviewed
in Burge, C.B., et al., 1998). Vertebrate exons are usually short (140 nucleotides on
average) while introns can be tens of thousands of nucleotides long. The recognition of
the splice sites is enhanced by interactions across the exon between splicing factors
recognizing the 3' splice site and splicing factors bound to the 5' splice site, in a process
called exon definition (Berget, 1995). A number of non-snRNP proteins take part in both
the constitutive assembly of the spliceosome and the regulation of alternative splicing.
Splicing regulators, most of which are RNA binding proteins, can modulate splicing by
binding constitutive consensus sequences at the splice sites, branch point and
polypirymidine tract, or specialized cis regulatory elements known as exonic enhancers
and silencers (ESE and ESS) or intronic enhancers and silencers (ISE and ISS).
Three not mutually exclusive mechanisms have been shown to be responsible for

alternative splicing in different cell types or in cells in different physiological condition
Transcription promoters can affect the pattern of splicing by recruiting splicing
factors to the promoter area through interactions with transcriptional activators bound to
transcription enhancers or with the Carboxy-Terminal-Domain (CTD) of the RNAP II, or
by affecting the processivity of RNAP II (see the section on coupling of transcription and
splicing).
Varying the concentration of general splicing factors in in vitro splicing assays or by
transfection in cell culture has been shown to affect the pattern of alternative splicing.
ASF/SF2 and hnRNP Al have been shown to have competing effects on the splicing of a
reporter minigene that could produce two splicing products differing in the usage of two
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alternative 5' splice sites. Excess ASF/SF2 has been shown to promote the utilization of
the more proximal 5' splice site. The addition of hnRNP Al competes the ASF/SF2

effect, promoting the usage of the more distal 5' splice site (Caceres et al., 1994;
Manley, 1990; Krainer et al., 1990; Mayeda and Krainer, 1992). HnRNP Al can promote

the usage of the most distal 5' splice site by reducing the occupancy of both 5' sp

sites by Ul snRNP, by cooperative binding that seems to be independent of the presen

of high affinity binding sites (Eperon et al., 2000). Furthermore, a number of studie

show that opposite actions of SR proteins and hnRNPs A and B regulate the inclusion

cassette exons. SR proteins usually activate the inclusion of cassette exons by bind

ESE sequences contained in the alternative exon and enhancing exon recognition, or b
antagonizing the repressing actions of hnRNP A or B bound to nearby ESS elements

(Zhu et al., 2001). HnRNP Al mediates silencing by recognizing initially a high-affin

binding site in the exon, which promotes the eventual interaction of hnRNP Al with t

upstream region of the exon, and possibly with intronic sequences (Zhu et al., 2001).
opposing effects of SR proteins and hnRNPs have been shown to regulate many RNAs in

a variety of systems (Bilodeau et al., 2001; Caceres and Kornblihtt, 2002; Caputi et

1999; Cartegni and Krainer, 2002; Dirksen et al., 2000; Hou et al., 2002; Marchand et

2002; Pollard et al., 2002; Smith et al., 2002; van der Houven van Oordt et al., 2000;
et al., 2002). The abundance of both hnRNP Al and ASF/SF2 was found to vary widely
across tissues, with variations in the molar ratio between the two proteins greater

100 times among certain tissues (Hanamura et al., 1998). It is conceivable that othe
general splicing factors belonging to the SR and hnRNPs families vary in a similar

across different tissues. Therefore, changes in the ratio between SR proteins and hn
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A/B may be crucial for the regulation of tissue-specific alternative splicing of a variety of
messages.
Another mechanism of alternative splicing regulation involves tissue- or

developmental stage-specific factors. At present, there are only few examples of suc

factors, and they have been mostly discovered in systems amenable to genetic screeni

This mode of regulation has been mostly investigated in the sex-determination cascad
Drosophila by a combination of genetic and biochemical means. The female-specific

factor Sex-Lethal (Sxl) inhibits the utilization of male-specific 3'splice sites in
Transformer (Tra) and on its own pre-mRNA. By competing with U2AF65 for the Tra

polypyrimidine tract, Sxl promotes the utilization of a downstream female-specific 3

splice site in exon 2, and the skipping of a stop codon that produces an inactive Tr

protein in male flies (Valcarcel et al., 1993). The female-specific Tra isoform, in t
promotes the cooperative binding of two proteins containing RS domains, RBP1 and

Tra2, to six ESEs in exon 4 of Doublesex (Dsx) pre-mRNA, which contains a stop codon

(Hertel and Maniatis, 1998; Lynch and Maniatis, 1996). Exon 4 is included in the Dsx

mRNA exclusively in female flies, resulting in an isoform of dsx that transcriptiona
represses several male-specific genes.
The Drosophila Half pint (HFP), which is expressed exclusively in the ovary in

the adult fly, specifically regulates the alternative splicing pattern of ovarian tu

eIF4E, and the constitutive splicing of gurken (Van Buskirk and Schupbach, 2002). The
mammalian homolog of Half Pint, PUF 60, does not seem to have conserved the tissue-

and target-specificity of HFP, and appears to have a rather general splicing activat
action (Maniatis and Tasic, 2002).
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The Drosophila neural-specific R N A binding protein E L A V (embryonic lethal

abnormal visual system) has been shown to be necessary and sufficient to produce th

neural specific splicing pattern of neuroglian (Koushika et al., 1996), erect wing (

and armadillo (Koushika et al., 2000). The effect on neuroglian splicing is dependent
the interaction of ELAV with uridine-rich intronic sequences (Lisbin et al., 2001).
However, a neural-specific vertebrate member of the ELAV/Hu family, HuD, when

expressed in Drosophila CNS under the control of an ELAV promoter, did not reproduce
the ELAV effect on the neuroglian pre-mRNA splicing (Toba et al., 2002).
Drosophila P-element somatic inhibitor (PSI), which is expressed exclusively in
the somatic cells, prevents the production of a functional P-element transposase by
inhibiting the excision of intron 3 (reviewed in Wang et al., 1997).

N O V A , A NEURON-SPECIFIC R N A BINDING PROTEIN

1) Paraneoplastic Neuro-degenerations:
The paraneoplastic neurologic degenerations (PNDs) are a group of very rare

neuronal degenerations described in patients suffering a neoplasia outside the nerv

system. It is a rather heterogeneous group of diseases, associated with various canc

and affecting different areas of the nervous system (reviewed in (Darnell and Posner

2003; Musunuru and Darnell, 2001). The immunologic nature of these diseases was first

suggested by the discovery that the patients have high-titer autoantibodies reactin

antigens in both tumor and central nervous system (Posner, 1992). The sera of patien

30

were used to screen c D N A expression libraries, leading to the identification of

autoantigens (reviewed in (Darnell, 1996). The targets of the autoantibodies were fou

to be proteins normally expressed exclusively in the neural system. It has been sugg

that the expression of neural specific proteins in tumors growing outside the CNS el

an immune response against those proteins, which are normally considered to be non-s

because of their exclusive location in the "immuno-privileged" environment of the CN
(reviewed in (Darnell, 1996).
Nonetheless, the observation that transfer of antibodies does not reproduce the

disease in animals suggests that the presence of autoantibodies is not sufficient to
the neurological degeneration (Darnell, 1996). Furthermore, most of the identified
onconeural antigens are intracellular. A cell-mediated mechanism in paraneoplastic

cerebellar degeneration has been unveiled based on the presence of expanded populati

of onconeural antigen-specific cytotoxic T lymphocytes in patients (Albert et al., 19
The cytotoxic activity of the T lymphocytes was shown to be much enhanced when the

onconeural antigen, deriving from cells undergoing apoptosis, was cross-presented to

T-lymphocytes by dendritic cells (Albert et al., 1998). While the presence of a prot
normally in immuno-privileged tissues in apoptotic cancer cells could lead to the

observed tumor immunity, the mechanism responsible for the neurologic degeneration i

still unexplained. It has been proposed that the auto-antibodies could enter neurons

lead to neuronal death by interfering with the physiological functions of the oncone
antigens (Musunuru and Darnell, 2001). Even a limited number of apoptotic neurons

could provide the antigenic material for cross-priming of cytotoxic lymphocytes, whi
would in turn trigger massive neural degeneration through a cell-mediated mechanism
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(Musunuru and Darnell, 2001).
The PND sera have proved a valuable reagent to identify a number of onconeural

antigens. Based on the biological characteristics, these exquisitely neuron-specific

proteins have been classified in four groups: neuromuscular junction proteins, vesic
associated nerve terminal proteins, neural signaling proteins, neuron-specific RNA-

binding proteins (Darnell, 1996). The two groups of RNA binding proteins identified a

onconeural antigens, Hu and Nova, are of interest for their potential role in tissue
regulation of different steps of gene expression.
Hu proteins are targets of autoantibodies in a set of PNDs called paraneoplastic
Encephalomyelitis and Sensory Neuropathy (PEM/SN), a condition most commonly

associated with small-cell lung cancer (SCLC), and some types of prostate cancer (Ba

and King, 1997; Dalmau et al., 1992a; Dalmau et al., 1992b; Manley et al., 1995). The
are four known Hu genes in mammals, termed HuA (or R) through D. While Hu B, C and

D are neural specific and autoantibody targets in PND, HuA is ubiquitous. Hu protein
have been reported to be involved in mRNA export (Gallouzi and Steitz, 2001),
stabilization of mRNAs containing AU-rich elements (ARE) in their 3'UTR (Fan and

Steitz, 1998) and translational control (Antic et al., 1999). Interestingly, Hu exert

opposite effects on translation depending on the location of its binding site in th

messages. Hu enhances translation of transcripts that interact with the protein in t

3'UTR (Antic et al., 1999), but exerts an inhibitory effect on the translation of p2

binding in the 5'UTR in a region of the transcript that functions as an internal ri

entry site (Kullmann et al., 2002). Overexpression of Hu in P19 and P12 cells and ect

expression in mouse embryos promotes a neural phenotype (Akamatsu et al., 1999; Ant
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et al., 1999; Gao and Keene, 1996). In mouse embryonic cortex a hierarchy of different
Hu messengers in neurons at different stages of migration was described (Okano and
Darnell, 1997).
2) POM A and the discovery of Nova:
The Paraneoplastic-opsoclonus-myoclonus-ataxia (POMA) is a neural

degeneration characterized by deficit of inhibitory control of the eye, limbs and tr
movements (Anderson et al., 1988; Budde-Steffen et al., 1988). It is a rather rare

complication of breast and gynecological tumors and small cell lung cancers. In west

blot analysis, sera from patients affected by POMA recognize two sets of four to fiv
bands in neural extracts, migrating slightly above 50 kDa and around 70 kDa

(Buckanovich et al., 1993). By screening expression libraries with POMA patient sera,
two genes were cloned, termed Nova-1 and Nova-2 (Buckanovich et al., 1993; Yang et
al., 1998). Nova-1 mRNA is expressed in neurons, mostly in the motor neurons of the

ventral horns of the spinal cord, in the motor neurons of the hindbrain and in ventr

midbrain (Buckanovich et al., 1993). Nova-2 mRNA is also exclusively neuronal, and it
distribution in the CNS is roughly complementary to that of Nova-1. Nova-2 is most

highly expressed in the cortex, olfactory bulb, thalamus, dorsal midbrain and inferi

olive, with weaker levels of expression observed in the hindbrain and spinal cord (Y

et al., 1998). Both Nova proteins are most abundant in the nucleus, but they are als

present in the cytoplasm and in the dendrites (Triller, A and Darnell, R.B., unpubli
observations).

3) Nova is a sequence specific RNA binding protein:
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Nova-1 and Nova-2 contain three repeats of the K H domain (hnRNPK Homology
domain), the second most common RNA binding motif, originally discovered in the

hnRNPK protein (Siomi et al., 1993). Since the characterization of the original KH mo
a superfamily of more than 100 KH proteins have been identified in eukaryotes,

eubacteria and archea (Lewis et al., 1999). KH motifs span about seventy residues, wi

characteristic a/p fold consisting of a three-stranded, antiparallel (3-sheet backed

a-helices, a Gly-X-X-Gly loop invariant among all the members of the superfamily, an
a variable loop (Lewis et al., 1999). KH-containing proteins play a functional role
splicing, as PSI in Drosophila, MER-1 in yeast, SF1 and KSRP in mammals, and in
translation, as hnRNPK, El and E2, and FMRP (Berglund et al., 1998; Brown et al.,

2001; Labourier et al., 2002; Min et al., 1997; Ostareck-Lederer et al., 1998; Spingo

and Ares, 2000) . Each Nova protein contains three KH motifs, the first two in the N
terminal half of the protein being separated by a short connecting region, with the
close to the C-terminus. A similar arrangement is observed in other KH domaincontaining proteins, like hnRNPK, hnRNPEl and E2. Nova-1 and Nova-2 are very

similar in their amino acid sequence: Nova-2 is 75% identical to Nova-1. The highest

level of sequence identity is observed in the KH motifs (87-93% amino acid identity)
Extensive in vitro Selection-Amplification studies have been performed to
identify specific RNA sequences that Nova binds with high affinity (Buckanovich and
Darnell, 1997; Jensen et al., 2000b; Yang et al., 1998). Selection-Amplification

performed with the entire Nova protein resulted in identification of a [UCAU(N)0_2]3

motif, in the context of a stem-loop structure (Buckanovich and Darnell, 1997). The s

study showed that the third KH domain was necessary and sufficient to bind the targe
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sequence. Additional R N A selection experiments performed with isolated K H 3 domain

resulted in the selection of a single UCAY motif in the context of a stem-loop struc

confirming the major role exerted by KH3 in the determination of the target sequence
the entire molecule (Jensen et al., 2000b).
This target RNA was co-crystalized with the isolated KH3 domain and the

structure was solved at 2.4 A resolution (Lewis et al., 2000). The single-stranded RN

sequence is pinioned between the invariant and the variant loops, and it stacks on a

hydrophobic surface made of aliphatic chains of amino acids belonging to a helices a
|3 strands. The central bases of the consensus sequence, C and A are specifically
recognized thanks to the spatial arrangement of several polar and charged residues
surrounding the hydrophobic surface, which mimic Watson-Crick-like C-G, A-U contact
(Lewis et al., 2000). The bordering residues on the two sides of the CA core of the
consensus sequence are also tightly specified, although less stringently, such that
pyrimidine can fit. Furthermore, the crystallized RNA/KH3 complexes arrange
themselves in dimers by interactions through their third a helix. This mode of
dimerization, which has been confirmed in solution by Nuclear Magnetic Resonance
(Ramos et al., 2002), would give the KH3 dimers the ability to bind two UCAY motifs,

agreement with the target consensus sequences selected by the entire protein, and wi

the few validated in vivo target sequences (see in the next sections), which all con

multiple repeats of the UCAY motif. The role of the first and second KH domains is n
clear at present; while differences in critical amino acids make it improbable that
recognize the UCAY motif, they could recognize other RNA sequences, further

specifying the in vivo targets, or participate in inter or intra-molecular dimer for
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or engage in interactions with other proteins (Lewis et al., 2000; Ramos et al., 2002).
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C h a p t e r

2

MATERIALS AND METHODS:

DNA preparation and restriction digest analysis
Unless otherwise stated, all plasmid DNA was prepared using Spin mini-prep kits
(Qiagen) and analyzed by restriction digestion using enzymes, buffers and protocols

supplied by New England Biolabs. DNA was separated by electrophoresis in standard lx
TBE/1-1.5% agarose gels and photographed under UV light. Plasmid DNA for
transfections into cell lines was prepared by a modified cesium chloride method
(Molecular Cloning, by Sambrook, Fritch and Maniatis, Cold Spring Harbor Laboratory
Press, 1989), and dialyzed against lxTBE.

Plasmid Constructs:
The GlyRa2 minigene (cloned in pCDNA3, Invitrogen) corresponds to the following
GlyRagr2 E2 mouse genomic sequences: bases 81-276 (GenBank accession number
X75842), 63-583 (GenBank accession number X75843), and 10-300 (GenBank
accession number 75844). The mutated GlyRa2 minigene, in which the Nova-1 binding
site 5'-UCAUCAUCAUUUUCAUUUUGUUU-3' was mutated to 5'-UAA
UAAUAAUUUUAAUUAAGGUU-3'. was generated by PCR. A cDNA encoding T7tagged Nova-1 was cloned into pcXHook (Invitrogen) and into pCI-neo (Promega).
The |3-globin minigene was generated by PCR using primers glo-KpnF and glo-

Rc using plasmid sp64-H|3A6 (a kind gift from A. Krainer) as a template, and was clo
into pCDNA3 (Invitrogen). Exon 2 was shortened by PCR. Heterologous minigene
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constructs were generated by PCR.
Mutations of both minigene and Nova-1 expression constructs were made with the
QuikChange Site-directed Mutagenesis Kit (Stratagene) and specifically designed
primers (Operon).
All DNA constructs generated by PCR were sequenced in their entirety.

Cell transfection
N2A and 293T cells were grown to 60% confluence in 6-well plates or chamber slides
10% FBS/DMEM with penicillin/streptomycin. For in vivo splicing assays, 2.25 jag of

total DNA, comprised of 0.25 ug of the appropriate minigene, and variable amounts of
pNova-1 and empty pclneo vector, were incubated with 95 ul of DMEM and 5 ul of
Fugene6 (Roche) for 15 min at room temperature. The mixture was then added to the

cells in a total volume of 2 ml 10% FBS-DMEM. After 40 hrs the cells were washed wit
lxPBS, collected by scraping and halved for RNA extraction and protein extraction.
Transfection in chamber slides was performed by adding a mix of 0.25 ug of plasmid,
ul of DMEM and 2 ul of Fugene6 to cells in a total volume of 1 ml 10% FBS-DMEM.

293T cells (ATCC) are a primary human embryonic kidney cell line transformed with th
SV40 T antigen. N2A cells (ATCC) are a mouse neuroblastoma cell line.

RNA preparation
Total RNA was extracted from mouse tissues using a modified guanidine-acid phenol

protocol (Chomczynski et al., 1997). RNA from tissue culture cells was purified using
RNeasy Mini kit system (Qiagen), including on the column DNase 1 digestion.
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RT-PCR

Purified RNA was reverse transcribed using random hexamers and Superscript II revers

transcriptase (Invitrogen). cDNA products were amplified using PfuTurbo (Stratagene)

with 40 pmol each primer, and 0.5 pmol of one y-32P-ATP-labeled primer. PCR products
were separated by denaturing PAGE (6% acrylamide/7 M urea) and confirmed by
sequencing. Quantification was performed using a Molecular Dynamics Storm
Phosphorimager and ImageQuant software. PCR was linear with respect to input cDNA
and cycle number (data not shown).

Western blot analysis

Tissue culture cells were lysed in PXL lysis buffer (lxPBS, 0.1% SDS, 0.5% DOC, 0.5%
NP-40). Proteins were separated by 10% SDS-PAGE and transferred to PVDF
membranes (Millipore). Equal loading of total protein was determined by Bradford

assay. Membranes were blocked for one hour at room temperature in 5% non-fat milk in
R buffer (0.15 M NaCl, 10 mM Tris-Cl, 1 mM EDTA, 0.1% Triton X-100), incubated

with HRP-conjugated anti-T7 tag monoclonal antibody (Novagen) in 5% milk in R buffer
at 4°C overnight and washed four times with alternating high salt (1 M NaCl, 20 mM
Tris-Cl, 0.1% Triton X-100) and high detergent (0.15 M NaCl, 5 mM EDTA, 50 mM

Tris-Cl, 1% Triton X-100, 0.05% SDS) buffers. After a final rinse with R buffer, sig
was detected by chemiluminescence (NEN). The membranes were wrapped (Saran
Wrap) and exposed on Biomax MR film (Kodak).
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Nitrocellulose Filter Binding Assays
Labeled RNA (100-200 nmol preheated to 75°C and bench-cooled 5 min) was incubated
with the indicated concentrations of protein. Protein-RNA mixes were incubated in a
volume of 50 pL SBB (200 mM KOAc, 10 mM TrisOAc [pH 7.7], and 5 mM MgOAc),
SBB 500 (500 mM KOAc, 10 mM TrisOAc [pH 7.7], and 5 mM MgOAc) or SBBhep

(SBB + 1 mg/ml heparin) for 10 min at room temperature. Binding solutions were passe
through MF-membrane filters (0.45 HA, Millipore) and washed with 5 ml SBB (or

SBB500). Data were plotted as percentage of total RNA bound versus log of the protei

concentration, and Kds were determined with Kaleidograph software (Synergy Software)
GABA was transcribed using T7 RNA polymerase and gel-purified PCR templates
generated using primers T7-GABA-9CF and xR' (wildtype, 159nt RNA) or i9AtoCR2
(mutant, 156nt RNA) and GABAARy2 minigenes as PCR templates. Glo RNA was

transcribed using T7 RNA polymerase directly from minigene glo2A digested with Bbsl,
to yield a 175ntRNA.

PCR Primers:
The primers used were
E2F: 5'-AGCTTTCTGCAAAGACCATGAC-3';
E4R: 5'-GAAGATCTCCAAATCCAAGGAATCATCTGGG-3';
agr2GlyRE3A: 5'-CATGGTGGTTTCTGTGACTGATC-3';
agr2GlyRE3B:5'-CATTGTAGTTTCTGCTATTGACCCAAAG-3';
agr2GlyRE4: 5'-TCCAAATCCAAGGAATCATCTGGG-3';
actinF:5'-GTGGGCCGCTCTAGGCACCA-3'
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actinR: 5 ' - C C C C C C T G A A C C C T A A G G C C A A C C G - 3 ' ;
mGluRlF:5'-CCTGGGGTGCATGTTTACTCC-3';
mGluRlR:5'-AGGCCGTCTCGTTGGTCTTCA-3';
ICH-1F: 5'-GTCTCATCTTCATCAACTCC-3';
ICH-lR:5'-ATGCTAACTGTCCAAGTCTA-3';
ClaBF: 5'-ACCGAACAGGAGTGGCGGGAG-3';
ClaBR: 5'-GGGGTCTCCTCCTTGGATTCT-3';
ggr2GABAF: 5'-GTATGGCACCCTGCATTATTTTGTC-3';
ggr2GABAR: 5'-TTGAATGGTTGCTGATCTGGGACG-3';
ChATF: 5'-ATGCCTATCCTGGAAAAGGTCCC-3';
ChATR:5'-AGTGCTCCGAGCAAAGATCACAG-3';
SrcF: 5'-CCAAGCTCTTCGGAGGCTTCAACTC-3';
SrcR: 5'-CACATAGTTGCTGGGGATGTAACCG-3';
AgrinF: 5'-GGGATAGTTGAGAAGTCAGTGGGGG-3';
agrin R: 5'-CGAAGCCAGCGGTTGGTGTTG-3'.
T7-GABA-9CF: 5'- GAAATTAATACGACTCACTATAGGGAGCAGCTGCA
CTGCTTAAGCGC-3'
xR': 5'- TTTTGCTAGCCACAATGTCATCAATGAGATGATG-3'
i9C-A R2: 5'- GTACTTCCACAATGTCATCAATTAGATTATTAATCTGAAAA
TTAGTATTCAG AAA ATTGCTT-3'

RT-PCR
Purified RNA (Chomcynski and Sacchi, 1987 ) was reverse transcribed using random
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hexamers, and c D N A products were amplified using PfuTurbo (Stratagene) with 40 pmol
of each primer and 0.5 pmol of one ggr-32P-ATP-labeled primer. PCR products were
confirmed by sequencing. PCR was linear with respect to input cDNA and cycle number
(data not shown).

In vitro Transcription and UV Cross-Linking
RNAs for crosslinking were generated by PCR using the wild-type or mutant GlyRagr2

minigene, followed by in vitro transcription. The primers used were T7primerl (sense
(5'-AGTAATACGACTCACTATAGGGATCATGCAGTTCTGGTTTAAT) and primer2
(antisense) (5'-AGCTCCATCAACATCTGTGG), which amplified a 90 nt fragment

surrounding the Nova-1 binding site. Gel-purified PCR products were used as template

for in vitro transcription. Thirty microliters of total cell extracts from mouse bra
(50 /d///g) were irradiated with UV light for 15 min. The samples were treated with
of RNAse A (Worthington) for 30 min at 37°C. UV cross-linking reactions were

immunoprecipitated with a 5 y\ polyclonal rabbit anti-Nova-1 antisera in a total vol
of 100 p\ of lysis buffer. The immune complexes were precipitated with protein
A-Sepharose beads (Sigma), run on 10% SDS-PAGE gels, transferred to nitrocellulose,
and exposed to film.
Purification of Nova-1 fusion protein:
Full length Nova-1 was cloned into pET21a (Novagen) and transformed into BL21
competent cells, followed by standard IPTG-induction and purification by nickelchelation chromatography. The fractions containing recombinant Nova were further
purified by affinity chromatography using an anti-T7 monoclonal antibody covalently
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coupled to cross-linked agarose beads (Novagen). The bound protein was eluted with 0.1

M citric acid, pH 2.2 directly in tubes containing 2 M Tris Base. Fractions containi

protein were pooled and affinity purified with a poly(G) resin (Sigma) and eluted i

0.5 and 1 M NaCl. The fractions were pooled, dyalized against buffer D and concentra
in Slyde-A-Lyzer concentrating kit (Pierce). Nova fusion protein preparation were

assessed for purity by electrophoresis on 5-20% polyacrylamide-SDS gels and Coomasi
blue (BioRad) staining.

In vitro splicing assay:
Substrates GABA/Globin A, B and mutant were transcribed in the presence of o>32PUTP. Transcription conditions were as follows: 40 mM Tris-HCl (pH 7.9), 6 mM MgCl2,
2 mM spermidine 0.5 mM ATP, CTP, GTP, 0.05 mM UTP, 1.65 pM ct-32P-UTP (ratio
cold UTP/labeled UTP= 30.3), 0.2 mM m7dG(5')ppp(5')G, 1 mM DTT, 3 pg template
DNA, 50U T7 RNA polymerase. The transcription mix was incubated 2 hrs at 37°C.

After treatment with Dnase I (final concentration 30U/ml) 20 min at 37°C, the produc

was gel-purified using a 6% polyacrylamide 7M Urea gel. In vitro splicing assays we

performed as described in Mayeda and Krainer, 1999. Briefly, the reaction was carrie
out in 25 \i\ total volume, with approximately 20 fmol of 32P-labelled, 7CH3-GpppGcapped substrate, in the presence of 0.5 mM ATP, 2 mM creatine phosphate, 3.2 mM
MgCl2, 2.6% (w/v) polyvinyl alcohol (PVA). The reaction contained 7.5 \x\ of HeLa
nuclear extract in buffer D (20 mM Hepes-KOH, pH 8.0, 0.2 mM EDTA, 20% (v/v)
glycerol, 100 mM KC1, 1 mM DTT, 0.5 mM PMSF), to which 1 to 3 pmol of NOVA-1
recombinant protein in buffer D were added. Following incubation for 4 hrs at 30°C,
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R N A was extracted with Tryzol L S (Invitrogen), precipitated and analyzed on a 6 %
Acrylamide-Bisacrylamide (19:1), 7M Urea, IX TBE gel. The gel was dried and

exposed. The intensity of the bands on the gel was quantified using a phospho imager

Debranching Assay:

Bands were cut out of polyacrylamide dried gel, crushed in extraction buffer (0.5 M
NH.Ac, 10 mM MgAc2, 1 mM EDTA, 0.1% SDS), eluted at 4°C for 6 to 12 hrs, and the

gel debris eliminated by filtering the slurry through a glass pre-filter. The recove
was precipitated. The de-branching assay was performed essentially as described in

(Ruskin and Green, 1990). Briefly, the RNA was incubated in the presence of 15 uJ. o
HeLa cytoplasmic S100 extract, 8 mM EDTA, in a final volume of 25u.l for 45 minutes

30°C. At the end of the incubation, RNA was phenol-chloroform extracted, precipitate
and analyzed on a denaturing gel.

Primer extension:

RNA template was purified from denaturing gels as described above for the de-branch

reaction. DNA primer antisense to the 3'splice site and polypyrimidine tract of the
32
intron of GABA/globin splicing substrate was labeled with

P-[y-ATP] and T 4

polynucleotide kinase, and gel purified. Around 25 Kcpm labeled oligo-primer was add
to around 5 fmol of eluted RNA in IX annealing buffer (AB) 50 mM Tris pH 8.3, 60 mM
NaCl, lOmM DTT in 6uJ total reaction volume and annealed by heating to 90°C for 3
min and letting slowly reach 45°C. Primer extension was performed using Superscript
reverse transcriptase (Invitrogen) according to the manufacturer's protocol.
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Immunoprecipitation from splicing reactions:
Immunoprecipitation from in vitro splicing reactions was performed essentially as

described (Blencowe et al., 1994). In vitro splicing reactions containing GABA/globi
substrate, GABA/globin B substrate in presence of 0.06 u.M recombinant Nova-1,
GABA/globin mutant substrate in presence of 0.06 uM recombinant Nova-1 were scaled

up seven times. Rabbit serum anti-mouse Fc was pre-adsorbed to protein A immobilized
on Sepharose beads (Sigma). After three washes in IP100 (50 mM Tris 7.45, 100 mM
NaCl, 2 mM MgCl2, 0.5 mM DTT, 0,05% (v/v) NP40), equimolar amounts of
monoclonal antibodies against Sm domain (Y12; Neomarkers), T7 tag (Novagen) and

purified mouse IgG (Pierce) were adsorbed to the protein A beads for 2 hrs at 4°C an

washed four times in IP 100. At the end of the four hrs incubation, the splicing re
were divided in four aliquots. Three aliquots from each reaction were used for

immunoprecipitation with each of the indicated antibodies, and RNA from the remainin
fraction was directly extracted as the input control. The aliquots used for
immunoprecipitation were twice the size of the one from which RNA was directly

extracted. After 1.5 hrs incubation at 4°C, the supernatant was removed and the pel
was washed three times in 1 ml IP100. The RNA was extracted from the
immunoprecipitated pellets with Tryzol, and analyzed on denaturing PAGE.

Yeast two hybrid assay:
Full-length Nova-1 cDNA was cloned into the LexA vector pBTM116, and transformed

into LD40 yeast strain. LD40 yeast are leu-/trp- and contain the lacZ and His-t- gen
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under the control of LexA promoters. The bait constructs (a kind gift of David Elliot,

MRC, Edinburgh, UK) were cloned in PAS vectors (Clontech). Transformations and tests
for protein-protein interactions (growth in tip-, leu-, his- medium and production

Galactosidase) were performed according to standard protocols (Sambrook et al. 2001)

GST pull-down assay in transfected cells:
In vivo GST pull-down assays were performed by co-transfecting N2a cells in 10 cm

diameter plates with constructs encoding the indicated proteins fused to GST subclo
in the PEBG eukaryotic expression vector (a gift of Dr. T Shishido), and vectors
encoding T7-Nova. Cells were harvested 2 days later, lysed in LB50: 20 mM Tris 7.5,
mM NaCl, 5 mM EDTA, 1% NP40, 1 complete tablet (Roche). Cells were sonicated,

debrees removed by centrifugation (14.000 X g, 5 min), and glutathione-sepharose 4B

(Pharmacia) beads were added. After overnight incubation, the beads were washed fiv
times with LB50. During the third washing step they were incubated in 23 u.g/ml
RNAseA for 20 min at 37°C. Proteins recovered in the pellet were analyzed by SDS
PAGE and western blot.

Sucrose Gradient centrifugation and Polysome Fractionation:

Analysis of polysomes from cell lines on sucrose gradient was performed using stand

protocols (Ruan et al., 1997). For each density gradient analysis of neural polysome

four spinal cords and hindbrains were dissected. Hypotonic Low Salt Buffer (20 mM T
7.4, 10 mM KC1, 5 mM MgCl2, 0.5 mM DTT, 1 complete mini EDTA free protease

inhibitor cocktail (Roche) for 10 ml of buffer, 100 ug/ml Cycloheximide (CH), Rnasin
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U/ml) was added to the dissected tissue in a proportion of roughly 0.25 ml of buffer for

each 0.1 mg of tissue. The tissue was then homogenized in a motor-driven Teflon-Glas
(900 rpm, 10 strokes), and nuclei were removed with a low speed centrifugation step
(2,000 X g, 10 min), and the supernatant (SI) was collected. A volume of detergent
solution (1.2% NP-40, 0.5 mM DTT, 100 [xg/ml CH, 1 complete mini EDTA free
protease inhibitors cocktail (Roche), Rnasin 20U/ml) equal to 25% of the SI volume,

a volume equal to 10% of the sum of SI and detergent buffer of High Salt Buffer (20m
Tris 7.4, 1.5M KC1, 3mM MgCl2, 0.5mM DTT, 1 complete mini EDTA free, lOOug/ml
CH, Rnsain 20U/ml) were added to the supernatant. Subsequently, we separated an ER
vesicle-enriched P2 fraction (or "bound" fraction) by centrifugation 20,000 X g for
min, from the S2, or "free" fraction. Deoxycholic Acid (DOC) was added to a final

concentration of 0.5% (w/v) to S2 and to the resuspended P2, a further centrifugati
20,000 X g for 10 min was performed to eliminate DOC-insoluble material, and the

supernatants were loaded on linear 20 to 50% (w/w) sucrose gradients in 20 mM Hepes,
pH 7.4, 150 mM KC1, 5 mM MgCl2. For the microarray assays, we did not fractionate
separately S2 and P2; we added DOC directly to SI, spun 20,000 X g for 10 min and

loaded the resulting "total" supernatant on the sucrose gradients. The gradients wer

centrifuged 200,000 X g in SW 41 rotors (Beckman) for 2 hrs. After the centrifugatio

gradients were fractionated using an ISCO fractionator while monitoring the absorba
at 254 nm.

RNA isolation and Oligonucleotide Array Expression Analysis:
For microarrays analysis, pooled spinal cords and hindbrains from four Nova-1-null
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animals were used for each replicate. A s control, spinal cord and hindbrains from wild

type or heterozygotes littermates were processed in parallel. One fifth of each lysa

used to directly extract the unfractionated "Total" RNA. Twelve fractions were colle

from each gradient, and RNA obtained from three polysomal fractions, as judged by th

UV254 absorption profile and by western blot with anti-PO ribosomal protein, was poo

The RNA extraction was performed initially by Trizol extraction (Invitrogen), follow

by a second purification and DNAse treatment step using the RNeasy kit (Qiagen). The
yield of RNA from the pooled polysomal fractions was 15 to 20 |u.g on average. The
synthesis of the probes for microarrays hybridization was performed as described at

http://www.affymetrix.com. The purified RNA is initially reverse transcribed using a
primer containing a 3' end oligo-(dT) and a 5' end T7 promoter sequence. Double

stranded cDNA is then transcribed presence of biotinilated UTP and CTPs, producing a

biotinilated cRNA probe, which is used for the hybridization. Hybridization and data
collection was performed by the Rockefeller University Gene Array Resource Center.
Data were initially collected in the Affymetric software MicroArray Suite, and then
transferred to Gene Spring software (Silicon Genetics). To allow comparison between

chips, the intensity value of each gene was normalized to the mean intensity value o

entire chip. Each gene represented on the chips is associated with four sets of inte

values defined by the experimental parameters: wild type total, wild type polysomes,

knock out total, knock out polysomes. Each set is made of three values, since the en
procedure was repeated three times. When comparing mRNAs in the polysome fraction
between wild type and mutant, we normalized the intensity values in the polysome

fraction to corresponding values in the total, to ensure that we were observing chan
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that occurred specifically in the polysomes.

Metabolic Phosphorylation assay:
N2a cells growing in 10 cm diameter dishes in Dulbecco-modified Eagle medium
(DMEM) supplemented with 10% Fetal Bovine Serum (FBS) were transfected with 5 \ig
of vector DNA encoding T7 tagged Nova-1 using 15 \xl of Fugene (Roche) according to

the manufacturer's instructions. When cells reached 70% confluence, usually after 40
incubation, the medium was substituted with Phosphate-free DMEM supplemented with

Dyalized FBS. After one hour incubation in Phosphate-free medium, inorganic 32P to a
final 0.5 mCi/ml was added to the dishes. After 5 hrs incubation at 37°C, the cells
harvested and lysed in 1 ml lysis buffer (1% NP 40, 0.5% DOC, 0.1% SDS, 0.15 M
NaCl, 0.01 M Na phosphate pH 7.2, 2 mM EDTA, 50 mM NaF, 0.2 mM Na2OV4, 1

complete protease inhibitor cocktail (Roche). Nova-1 was immunoprecipiated with 5 ]x

anti-T7 tag monoclonal antibody (Novagen) after a pre-clearing incubation with a pre
immune mouse serum adsorbed to protein A beads. The pellet was washed five times
with lysis buffer. After the second washing step, the pellet was resuspended in TBS
containing 2 mg/ml RNaseA and 3,000 U/ml RNase Tl, and incubated 15 min at room

temperature. After the last washing step, the pellet was resuspended in 2X SDS loadi

buffer, resolved by electrophoresis on SDS-PAGE, transferred to a nylon membrane and

exposed to a radiography film. The identity of the bands observed by autoradiography
was confirmed by western blot.

Immunofluorescence of cell cultures:
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For immunofluorescence of cell cultures, cells were plated onto chamber slides (Nalge

Nunc), transfected where appropriate, and two days later rinsed with PBS, fixed (10 m

in 2% paraformaldehyde in PBS at room temperature), washed, permeabilized (10 min in
0.5% NP-40 in PBS at room temperature), washed again, blocked (1 hr at room
temperature in PBG: 0.2% gelatin and 0.5% bovine serum albumin in PBS) and stained

overnight with primary antibody in PBG at 4°C. After three washes in PBG, slides wer
incubated with fluorochrome-conjugated secondary antibodies in PBG for 1 hr at room
temperature in the dark. Slides were then washed three times in PBG, once with DAPI
PBS, and once in PBS alone. Slides were left at room temperature to dry and then
covered with mounting medium (Biomeda) and a coverslip (Fisher) before being sealed

with nail polish. The slides were observed under multiple wavelength fluorescence fr
a mercury lamp (AttoArc), in an upright microscope (Zeiss Axioplan). Pictures were
taken with a digital camera (Hamamatsu Orca), using Openlab software (Improvision)
and presented with Photoshop software (Adobe).
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3

1) Role of Nova-1 in the regulation of alternative splicing:
Introduction: In vitro RNA selection studies have identified the consensus
sequence (UCAUY)3 as a high affinity binding target for Nova-1 recombinant protein

(Buckanovich and Darnell, 1997; Jensen et al., 2000b). In an attempt to identify RNA
sequences that Nova-1 binds in vivo, public databases and a compilation of neuron-

specific alternatively spliced exons and their surrounding introns (Stamm et al., 19

were analyzed. Two candidate target sequences were identified in this way, both in a

intronic location close to alternatively spliced exons. Only two potential Nova-1 in

RNA binding sites were initially identified, one within an intron of the Glycine Rec

al subunit (GlyRa2 ) pre-mRNA (Kuhse et al., 1991), and one in an intron of the Nova
1 pre-mRNA itself (Buckanovich and Darnell, 1997). While these pre-mRNAs were
shown to be indeed associated with Nova-1, by co-immuno-precipitation of the RNAs

bound to Nova-1 followed by RT-PCR with specific primers, proof that the native Nova
protein from mouse brain is able to directly bind the Gly R a2 intronic (UCAUY)3
element was still lacking.
Results: To address this question, a 90 nt intronic RNA surrounding the Gly R a2
(UCAUY)3 element was transcribed in the presence of 32P-UTP, and ultraviolet (UV)

cross-linked to proteins in brain extracts. As a control, we also transcribed a muta
R a2 RNA, (UAAUY)3, previously shown not to bind Nova-1 in vitro (Buckanovich and
Darnell, 1997) (Fig. IA). These mixtures were RNase treated, and Nova protein was
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immunoprecipitated, run on S D S - P A G E gels, and transferred to nitrocellulose. A 32Plabeled RNA band superimposable on the 55 kDa Nova protein band was seen

specifically in immunoprecipitates of extracts cross-linked to the wild-type (UCAUY)
but not the mutant (UAAUY) 3 RNA (Figure IB). This result demonstrates that native
neuronal Nova protein specifically binds to the Gly R a2 intronic (UCAUY) 3 RNA.
The location of the Nova-1 binding sites in introns in the proximity of

alternatively spliced exons suggested the possibility that Nova-1 could modulate the

alternative splicing of its target RNAs. We examined whether Nova-1 is able to direc
act on GlyRa2 pre-mRNA to regulate alternative splicing of the E3A/E3B exons. We
generated a minigene construct consisting of genomic DNA encoding GlyRa2 E2, E3A,
E3B, and E4 and several hundred nucleotides of intronic DNA on either side of these

exons (Figure 2A). To allow us to determine whether Nova-1 acts directly on the GlyR

intronic (UCAUY)3 element, we also generated a mutant minigene in which this element
was mutated to the nonbinding (UAAUY)3 sequence. These constructs were then

transfected into three different cell lines along with increasing amounts of a plasm
expressing Nova-1 (pcNova-1). The total amount of DNA transfected in each well was
normalized by transfecting appropriate amounts of empty vector DNA. 48 hours after
transfection the RNA was extracted, reverse transcribed and amplified by PCR using
primers specific to GlyRa2 E2 and GlyRa2 E4. Since the splicing products including
exon 3a and exon 3b are exactly the same size, reaction products were digested with
restriction enzymes that specifically recognized sites either in E3A (Sspl) or E3B
(BspMI). We confirmed that these enzymes uniquely recognized E3A or E3B (with

>98% specificity; data not shown). Nova-1 transfection mediated an increase in GlyRa2
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E 3 A splicing in each of the three cell lines tested. Figure 2B illustrates the results of

splicing assays performed on extracts of a neuroblastoma cell line, N2A, transfected
the wild-type (UCAU) or mutant (UAAU) GlyRa2 minigene in the presence or absence
of pcNova-1. A Nova-1 dose-dependent increase in splicing to E3A (and compensatory

decrease in E3B) is evident in cells transfected with the wild-type UCAU but not the
mutant UAAU GlyRa2 minigene. We demonstrated that increasing amounts of pcNova-1
vector led to increasing amounts of Nova-1 protein by Western blot analysis (Figure
To confirm these results and analyze splicing to both E3A and E3B, we repeated
independent transfection experiments in N2A cells (Figure 2D). In cells transfected
the wild-type UCAU GlyRa2 minigene, Nova-1 reproducibly mediated a two-fold
increase of E3A splicing at the expense of E3B splicing.
In N2A cells transfected with the mutant UAAU GlyRa2 minigene, splicing to

E3A was unchanged relative to the wild-type minigene (Figure 2D). In the presence of

increasing amounts of Nova, an increase in E3B, at the expense of E3A, was seen. Whi

the mechanism underlying this observation is unclear, a possible explanation is that
UAAU mutation allowed detection of a cryptic Nova-1 binding site able to mediate an

action on E3B splicing. Taken together, these results demonstrate that the action of
to enhance E3A utilization in wild-type UCAU GlyRcc2 pre-mRNAs was abolished by
mutation in the intronic UCAU Nova-binding element.
We repeated these experiments in HeLa cells and 293T cells, two non-neuronal

cell lines that do not express Nova (Figure 2E and Figure 2F; data not shown). pcNov

cotransfection with the wild-type GlyRa2 minigene mediated a 2.5-fold increase in E
splicing in HeLa cells and a 2-fold increase in 293T cells. Some additional effects
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seen. In H e L a cells, the increase in E 3 A splicing was at the expense of E3B, while in

293T cells the increase in E3A-spliced product was inversely proportional to a decre
in an aberrant spliced product that contained neither E3A nor E3B (E2-E4; data not
shown). We also found that in cells transfected with the mutant UAAU GlyRo.2

minigene, in the presence of Nova there was no increase in E3A splicing but again an

increase in E3B splicing, and in the absence of Nova there was a small but consisten
increase in E3A splicing that is unexplained. Taken together, these experiments

demonstrate that Nova-1 is able to act directly to enhance the inclusion of GlyRa2 E

in cell lines and that this action is dependent on the integrity of the intronic UCA
binding site.
The effects of transfected Nova on GlyRa2 minigene alternative splicing are in
agreement with the effects of lack of Nova-1 on GlyRa2 splicing observed in Nova-1-

null animals (Jensen et al., 2000a). Nova-1 null mutant mice, generated by homologou

recombination, are viable and phenotypically indistinguishable from their littermate

birth. Thereafter, they demonstrate progressive motor dysfunction and die an average

10-15 days after birth. Prior to their death, Nova-1 null mice exhibit an action-ind
tremulousness and overt motor weakness, although they maintain normal responses to
sensory stimuli. There is no abnormal phenotype in Nova-1 heterozygotes. Histologic

examination and TUNEL staining of Nova-1 null mice revealed a 4-fold increase in th

number of picnotic cells in the areas of the CNS expressing Nova-1 relative to litte
(Jensen et al., 2000a).
Since GlyRa2 gene expression and physiology in rodent spinal cord and

brainstem undergo regulation after the first week of postnatal life (Bechade et al.,
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Kuhse et al., 1991; Singer et al., 1998), GlyRa2 splicing was examined at various ages in
Nova-1 null mice using RT PCR and RNAse protection assay. These studies
demonstrated that the ratio of E3A/E3B splicing was decreased in Nova-1 null mice

relative to wild-type littermates by 2-fold. Importantly, splicing defects in Nova-

animals were limited to spinal cord and hindbrain, the areas where Nova-1 is normall

expressed (Jensen et al., 2000a). These results are consistent with our transfection
which Nova-1 acts to enhance the utilization of GlyRa2 E3A, while in the absence of

Nova-1 in vivo there is a relative deficit in the ability of neurons to utilize the
site.

2) In vitro assay of Nova action in alternative splicing:
We sought to characterize the mechanism through which Nova achieves regulation of
alternative splicing by establishing an in vitro assay. Attempts to recapitulate in

alternative splicing pattern of GlyRa2 failed, probably due to the size of the four-

construct and the complexity of the splicing choices (data not shown). We then turne
another target pre-mRNA, which emerged from the analysis of the Nova-1 null animals

as a target for Nova-1 regulation. Alternative splicing of the GABAA receptor yl sub

(GABAARy2) was significantly altered in Nova-1 null mice (Jensen et al., 2000a). The
GABAARy2 transcript is widely expressed in the brain, and the pre-mRNA is

alternatively spliced to include the cassette exon 9 preferentially in brainstem an
neurons (Zhang et al., 1996). In Nova-1 null animals, the ratio between the exon 9-

including and exon 9-excluding forms (called L and S, respectively) was decreased th

fold, suggesting a role for Nova-1 in promoting the inclusion of the alternative exo
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(Jensen et al., 2000a).
The effect of Nova-1 on GABAARy2 pre-mRNA has been further characterized

by transfection of minigenes in heterologous cell lines (Dredge and Darnell, in press

these studies, a modified version of SP64-H(3A6 (Krainer et al., 1984) was employed,

which the length of the middle exon was reduced to 24 nucleotides to attain a rough

ratio between the form including and the form excluding the alternative exon when t
minigene was transfected in 293T cells. The second intron was also shortened. By
inserting progressively shorter sequences from intron 9 of GABAARy2 in the second
intron of this minigene, a sequence of 24 nucleotides was identified, that was able

confer Nova-dependent regulation of the inclusion of the alternative exon (Dredge a

Darnell, in press). The 24 nucleotide Nova-dependent intronic splicing enhancer (NISE
contains four UCAU repeats, and their mutation to UAAU completely abolishes the
Nova-1 effect on alternative splicing (Dredge and Darnell, in press).
We resolved to utilize the two constructs Globin/GABA 1 and 2 to test the effect

of Nova-1 in an in vitro splicing assay. Globin/GABA 1, containing 68 nucleotides of
GABAARy2 sequences, was the construct showing the most prominent effect of Nova-1

in transfection, where the ratio between the long, alternative exon including form (

the short final product of splicing (S) increased around ten times in response to N

transfection (Dredge and Darnell, in press). Globin/GABA 2 is the construct containin

the minimal 24 nucleotides NISE sequence necessary to enable a Nova-dependent effec

on splicing. The ratio between the L product and S product increased around six time
response to Nova-1 co-transfection for the Globin/GABA B construct (Dredge and
Darnell, in press).
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Nova was purified as a fusion protein containing a six-histidine tag at its C-

terminus and a T7 tag at its N-terminus. Three sequential affinity chromatography st
were used in the purification protocol. The protein was initially bound to a Nickel

through its poly-Histidine tag, and then further purified using an immobilized mono

antibody against the T7 tag. A final ribohomopolymer poly(G) column was deployed to

selectively recover protein still able to bind RNA after the acidic elution from th

antibody column. The resulting fusion protein was almost 100% pure by Comassie stain
(Fig. 3A) and able to bind its target RNA with high affinity and specificity (Fig.
We performed in vitro splicing assays using HeLa nuclear extracts supplemented

with purified recombinant Nova protein and body-labeled RNA. After 4 hrs of incubat
the RNA was extracted and analyzed on a denaturing gel. The identity of the bands

corresponding to the unspliced RNA, the two alternative products of splicing and ex

(Fig. 4A and 5A) was defined by reverse transcription using an antisense exon 3 or 1

primer, PCR amplification, cloning of the products and sequencing. Two substrates we

initially tested, one corresponding to the globin/GABA 2 containing 24 nucleotides N
and a mutated version in which the UCAU repeats were mutated in UAAU (Fig. 4B). The
presence of recombinant Nova in the reaction mix reproducibly resulted in a dose-

dependent increase of the inclusion of the alternative cassette exon in the final p
splicing (Fig. 4A). The maximal increase is close to 2-fold and is observed with a

concentration around 0.12 uM (quantified by Bradford assay), or a molar ratio of Nova

1:RNA of about 100:1 (Fig. 4C). Higher concentrations of Nova-1 in the reaction mix

not result in a further increase in the ratio between the long and the short product
reaches a plateau and decreases (Fig. 4C and data not shown). Mutation of the GABA
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N I S E repeats results in the abolition of the ability of Nova-1 to promote inclusion of the
alternative exon (Fig. 4C).
In addition to these observations, we noted that a band migrating at an apparent

size of around 260 nucleotides appears to dramatically increase in response to incr
concentration of recombinant Nova-1 in the reaction mix (Fig. 4A, indicated with a

star). The size of the band does not correspond to any of the predicted products or s

spliced intermediates of the splicing reaction. Furthermore, the in vitro splicing r

of globin/GABA 1 substrate, which is completely identical to globin/GABA 2 but for 4

more nucleotides of sequence derived from GABAARy2 (Fig 5A), results in an identica
pattern of bands but for a band that becomes more prominent in a Nova-dependent

fashion and migrates at an apparent size of more than 400 nucleotides (Fig. 5B, ind

with a blue star). The lack of correlation between the rate of migration of these tw

and difference in molecular size of the two RNAs suggests that they are lariats, spl

introns whose rate of migration is affected by the presence of a branching site (Ru
al., 1984).
The identity of these two Nova-enhanced bands was determined by incubating the
RNA eluted from the gel with S100 cytoplasmic extract from HeLa cells. S100 extract
contains a 2', 5' phosphodiesterase or de-branching enzyme (Ruskin and Green, 1985).
The de-branching activity of S-100 extract induces a shift in the apparent size of
aberrantly migrating bands: the band deriving from splicing of globin/GABA 2 shifts

from an apparent size of 260 nucleotides to a size compatible with the second intro
globin/GABA 2, which is 181 nucleotides long (Fig. 6A, compare bands 3 and 4); the
band deriving from globin/GABA 1 shifts from an apparent size of more than 400
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nucleotides to a size compatible with the second intron of globin/GABA 1, which is 225

nucleotides long (Fig. 6A, compare lanes 7 and 8). This assay also suggests that th

migrating slower than the unspliced RNA correspond to the lariats including both th

introns and the alternative exon that result from the skipping of the alternative e

splicing reaction (Fig. 6A, compare lanes 10 to 9 and 12 to 11). As a negative contr
RNAs which do not contain lariats, the unspliced precursors, do not undergo any
modification of their rate of migration in gel electrophoresis as a consequence of

treatment with S100 extract (Fig. 6A, compare lanes 2 to 1 and 6 to 5). The apparent

migration rate of lariat-containing RNAs is affected by the ratio between the sizes
linear and the circularized portions of the molecule, and therefore by the position

branching point (Grabowski et al., 1984). To determine whether part of the difference

the apparent rate of migration between the lariats observed in the globin/GABA 1 an

globin/GABA 2 splicing reactions was due to the utilization of two different branch
sites, induced by the insertion of GABAARy2 sequence of different length and
composition, we mapped the branching point in the two lariat eluted from the gel by

primer extension. The primer extension is stopped at the same site in the two lariat

demonstrating that the same branching point is utilized in the two constructs (Fig.
Finally, the de-branched lariat from globin/GABA 2 was eluted from the gel, two RNA

linkers were ligated at the 5' and 3' ends, reverse transcription and PCR amplificat

was performed using primers complementary to the linkers, the product was cloned and
sequenced, identifying it as the precisely excised second intron (data not shown).
The dose-dependent increase of the second intron lariat-product in response to
Nova-1 protein suggests that the presence of Nova promotes the excision and/or the
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stability of the second intron. The two actions (excision stimulation and stabilization) are
not mutually exclusive, and it is difficult to discriminate between them, since an
increased recruitment of splicing factors dependent on the presence of Nova on the

second intron will eventually result in stabilization of the spliced intron. If spli

activation by Nova depends on an enhanced recruitment of splicing factors on the in
Nova binds to, interactions with constitutive splicing factors are expected.
Previous yeast-two-hybrids screenings using Nova as a bait and libraries of

embryonic and adult brain cDNAs as preys led to identification of a neuron-enriched

PTB-like novel gene (Polydorides et al., 2000) and SRp20 (Yang et al., unpublished),
among others, as interacting partners of Nova-1. The interaction with the PTB-like

protein has been characterized in detail, and an antagonistic effect of brain PTB on

splicing activation mediated by Nova has been demonstrated (Polydorides et al., 2000)
The interaction with SRp20, which has been shown in several instances to act as a

splicing activator (Cavaloc et al., 1999; Jumaa and Nielsen, 1997; Lim and Sharp, 199

offers a potential mechanistic explanation for the activating effect of Nova-1 on e

inclusion. SRp20 is part of the large family of the SR proteins (reviewed in Gravele

2000), and the RS domain, consisting of repeats of Arginine and Serine residues, is f

not exclusively in the SR protein family, but also in a number of other nuclear prot

and it has been characterized as a protein-protein interaction motif (Graveley, 2000)

order to control the specificity of the interaction between SRp20 and Nova, we scree

several members of the SR protein family and other SR-related proteins by yeast-twohybrid assay. Interestingly, some members of the SR proteins family, like SRp20 and
9G8, and the SR-related U2AF65, Ul 70K and the U2AF65-interacting protein HUAP
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56, were found to interact with Nova, while others, like SC35, ASF/SF2, SRp30c, SRp40
and the SR-related protein U2AF35 did not (Fig. 7A). Nova-1 and the closely related
Nova-2 were found to interact with the same set of proteins.
The interaction of these proteins was assessed in mammalian cells by co-

transfection assays. 293 T cells were co-transfected with cDNAs encoding two isoform

of Nova-1 generated by alternative splicing (Nova-1 H+ and H-, see in the next sect

tagged with T7 and several proteins tested in the yeast-two-hybrid assay fused with
The cell lysate was RNAse treated and the GST fusion proteins were absorbed to GTTcoated beads and the presence of complexes with Nova-1 was verified on western blot

with antibodies against the T7 tag. As shown in figure 7B, the interaction of Nova-

U2AF65 (lane 3) and Ul 70K (lane 4) were confirmed in this assay, the interaction wi

HUAP 56 was confirmed in a separate set of experiments (data not shown). Surprisingl

the interaction with SRp20 was not confirmed in this system. The interaction with 9G

was not tested in this system. Furthermore, Nova-1 was shown to interact with itself

transfected cells (lane 1), in agreement with the structural studies in crystals an

solution (Lewis et al., 2000; Ramos et al., 2002), and with HuD, as previously shown
(Okano and Darnell, unpublished). The recovery of T7-Nova-l was overall inefficient

(<1% of the total T7 Nova). These data show that Nova-1 is capable of interactions w

a subset of splicing factors containing RS domains although, given the limited set o
potentially interacting proteins we considered, interactions with other factors are
The demonstrated association of Nova-1 with ninety nucleotides of the intronic

sequence of GlyRa2 (Fig. 1) and the dose-dependent increase of the lariat product (

5A) of globin/GABA constructs suggest that Nova first binds to the intronic sequenc
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the regulated pre-mRNA. However, we have not directly verified if Nova-1 binds to the
full-length pre-mRNA in the context of assembled spliceosomes, nor if it remains
associated with intermediates or products of splicing. To address these issues, the

antibody against the T7 tag was used to immunoprecipitate splicing complexes assembl
in vitro either on globin/GABA B (Fig.8A, lanes 4 and 12) or globin/GABA mutated in

the UCAU repeats (Fig.8A, lane 8). The positive control, anti-Sm monoclonal antibody
Y12, recognizes the common Sm snRNPs (Lerner et al., 1981), and has been shown to
immunoprecipitate pre-mRNAs, intermediates and products of various RNAs engaged in

spliceosomes in vitro (Black et al., 1985; Chabot and Steitz, 1987; Chou et al., 199
Grabowski et al., 1985). As expected, Y12 immunoprecipitates the unspliced pre-mRNA
as well as intermediates and products of the splicing reactions of globin/GABA wild

and mutated (Fig. 8A, lanes 3, 7, 11). The protein A beads adsorbed with purified mo
IgG precipitate trace amounts of various RNA species (Fig. 8a, lanes 2, 6, 10). The

T7 antibody, which in the absence of exogenous T7 tagged-Nova-1 does not precipitate
RNAs above background levels (lane 4), efficiently precipitates various RNA species
the presence of recombinant Nova-1 (lanes 8 and 12). The precipitation of unspliced
mRNA was nearly as efficient as with Y12 (compare lane 11 and 12) and the

precipitation of intron 2 lariat product was more than three times more efficient in
wild type RNA reaction than in the mutant (compare lanes 8 and 12). These results

indicate that Nova-1 is bound to the full-length pre-mRNA in the course of the splic

reaction. The immunoprecipitation of splicing intermediates indicates that Nova-1 is

present in the pre-mRNA complexes containing the spliceosome, and it is not dissocia

from its substrate during spliceosome assembly and the splicing reaction. Interestin
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sizable amount of the long product of splicing is recovered in the Nova-1 pellets. While
the ratio between the long and the short product in the pellet of the Y12

immunoprecipitation is exactly equal to the ratio between the two products in the to
reaction (compare lanes 11 to 9 and 7 to 5, and Fig. 8b), there is an enrichment of

long form of almost two times in the pellet of the anti-T7 immunoprecipitation (comp

lanes 12 to 9, and Fig.8b); the mutation of the Nova binding site in the second intr
abolishes such enrichment (compare lanes 8 to 5, and figure 8b).

3) Discussion:
The results shown demonstrate that Nova is capable of affecting alternative

splicing of artificial constructs in a way consistent with the results obtained in v

Nova-1-null mutant mice. Nova-1 present in brain extracts specifically cross-links t
sequence (UCAUY)3 but not the mutant sequence (UAAUY)3, consistent with previous
co-immunoprecipitation experiments demonstrating that Nova-1 protein binds GlyRa2
pre-mRNA in vivo (Buckanovich and Darnell, 1997). In cotransfection assays, GlyRa2
pre-mRNAs harboring this (UCAUY)3 sequence show a Nova-1 dose-dependent increase

in utilization of the alternatively spliced E3A, while mutant pre-mRNAs harboring th
(UAAUY)3 point mutant do not show this effect. In Nova-1 null mice, there is a

reciprocal 2-fold decrease in the ratio of GlyRa2 E3A relative to E3B splicing (Jen
al., 2000a). These data provide converging lines of evidence that Nova-1 regulates
GlyRa2 splicing by directly binding to the pre-mRNA in neurons.
Potential mechanisms for Nova action in alternative splicing regulation: The

abolition of the effect of Nova on splicing by mutations of the Nova binding site bo
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transfected cells and in vitro supports the notion that the binding of Nova-1 to its
substrates is required for regulation of alternative splicing. Furthermore, the observed

ability of recombinant Nova-1 to recapitulate in vitro the regulation of alternative splicing
shows that at least part of the action of Nova is post-transcriptional and limited to the
splicing step. In identified pre-mRNAs in which Nova-1 promotes the inclusion of an
alternatively spliced exon, GlyRa2 and GABAARy2, the Nova binding site is situated in
an intron 80 nucleotides upstream of a 3'splice site. While in the GlyRa2 case Nova
binds to the intron preceding the exon whose inclusion is promoted by Nova, in the
GABAARy2 pre-mRNA Nova binds to the intron downstream of the regulated exon.
Thus, in the first example Nova binds an intron whose 3' splice site undergoes regulated
splicing, while in the case of the second intron of GABAARy2 (and of GABA/Globin

constructs) the 3' splice site is constitutively spliced and the 5' splice site is alternativ
utilized (compare schemes in figures 2A and 4B). In both cases Nova-1 promotes the
utilization of the alternative splice site more proximal to its intronic binding site.
The search for basic components of the splicing machinery interacting with Nova

resulted in factors that participate in the recognition of both 5' and 3' splice sites. Ul 70K
is a component of Ul snRNP, whose snRNA anneals to the 5' splice site consensus
sequence, and U2AF65 recognizes the polypyrimidine tract, close to the 3' end of the
intron. These data suggest that Nova binds to specific sequences in the intron and recruits

splicing factors through protein-protein interaction, stabilizing their interactions with the
most proximal splicing sites and ultimately promoting the excision of the shorter version
of the intron it is bound to. Consistent with this idea, in the only in vitro model available
of a minigene regulated by Nova-1, the lariat product of the intron bound by Nova is
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increased in a dose-dependent manner. After four hours of incubation in nuclear extract,

the splicing products visualized in the urea PAGE are most probably the ones that we

protected from the nucleases present in the extract because they were engaged in pro

RNA complexes. The increase of the lariat product in response to Nova may result fro

two mechanisms: a) increased production (by increased splicing) and stabilization by

recruited U2/U5/U6 snRNPs or b) protection from nucleases through multimerization of
Nova-1 from the initial high affinity binding site to cover the rest of the excised
analogously to the described behavior of Rev (Malim and Cullen, 1991), therefore
independently of spliceosome recruitment. The second hypothesis does not seems very

probable, since the interaction between Nova and its target RNA has always been foun

to be restricted to the UCAU repeats, when characterized with various RNAse protecti
techniques, even at very high protein/RNA ratios (Dredge and Darnell, unpublished).

Furthermore, the excised lariat is precipitated also by anti Sm-antibody, suggesting

is part of a complex with snRNPs. Therefore, although we have not directly demonstra

an increased level of spliceosomal complex formation in response to Nova-1, the simp

explanation for the increased levels of lariat product is that Nova stimulates the e
of the intron through recruitment of components of the spliceosome.
While the enhanced recruitment of the spliceosome to the intron bound by Nova
is a probable mechanism through which Nova regulates alternative splicing of target

mRNAs, alternative scenarios cannot be ruled out at present. A construct made of the
and second (alternative) exons of the globin/GABA minigene fused together, followed

the second intron and the third exon, failed to show any enhanced splicing in respon

increasing level of Nova in transfection and in vitro (data not shown). This lack of
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m a y be due to the high efficiency with which this construct is spliced constitutively,
probably due to the close match to the consensus sequence of both the splice sites,
polypyrimidine tract and branch point. A second competing 5'splice site is required for a
Nova effect to be observed in this artificial construct. In both the GABA/Globin artificial
construct and in the GABAARy2 pre-mRNA, the 3' splice site of the first intron is weaker

then the 3'splice site of the second, due to one and four purines, respectively, interrupting
the polypyrimidine tract. An alternative way Nova could promote the inclusion of the
cassette exon is by favoring the utilization of the weaker acceptor. This could be achieved
by inhibiting the utilization of the constitutive 3'splice site, a mechanism opposite to the
recruitment of components of the spliceosome we discussed above. A slower kinetic of
the pathway leading to the exclusion of the alternative exon would unbalance the reaction
in favor of the inclusion of the cassette exon. The described interaction of Nova with PTB
and brPTB, a brain enriched gene similar to PTB (Polydorides et al., 2000), offers a
possible mechanism for such inhibitory effect. However, this second hypothetical
mechanism is difficult to reconcile with the GlyRa2 splicing regulation, where a slower
kinetic of the utilization of the 3'splice site closer to the Nova binding site would lead to
an increased inclusion of exon 3B, an opposite effect to what we observe in the presence
of Nova.

Interestingly, we observed that some Nova is also associated with the spliced
product. Furthermore, there is specifically an enrichment of the long, exon-including
form in the Nova pellet. While we have not directly tested if Nova is able to bind the
exonic sequences of our construct, there are no obvious consensus Nova-binding sites in
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the exons, nor they are created by the fusion of the exonic sequences by splicing.
Therefore, the association of Nova-1 with the spliced product could result from
interactions with the same components of the splicing machinery that Nova-1 helped

recruit to the intron. The spliced products are indeed precipitated also by the anti
antibody in our assay, suggesting that they are not completely disengaged from the

splicing machinery. An alternative, albeit not incompatible explanation, is that Nov
remains associated to the splicing product through interactions with components of
exon junction complex. The observed interaction between Nova and UAP56 provides a

possible mechanism for such interaction. UAP56, a DEAD motif containing helicase, ha
been described as a factor coupling splicing and RNA export. UAP56 is required for
interaction between U2 snRNP and the branchpoint (Fleckner et al., 1997), and it is

eventually necessary for the recruitment of the mRNA export factor Aly to the splic
mRNP (Luo et al., 2001; Strasser and Hurt, 2001). Further experiments, in particular

purification of the mRNP through centrifugation on linear density gradient, are requ

to verify whether Nova is associated with the spliced RNA in the context of a mature
mRNP. The "tagging" with Nova molecules of mRNA resulting from alternative splicing
regulated by Nova could offer an interesting mechanism to couple nuclear events of
processing to the downstream steps of export, localization and translation.
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Figure 1: Nova-1 protein from C N S lysates binds the predicted site in GlyRct2
intron.
(A) The 90 nt of GlyRa2 pre-mRNA sequence surrounding the Nova-1 binding

consensus site. The mutations of the site are indicated in light blue. (B) An extrac

mouse brainstem was incubated with the 90 nt 32P-labeled RNAs shown in A., encoding

either the GlyR ct2 UCAU intronic sequence (lanes 1, 2) or mutant UAAU RNA (lanes 3

4). Samples were UV cross-linked, RNase treated, and immunoprecipitated with either

rabbit anti-Nova serum (lanes 1, 3) or pre-immune serum (lanes 2, 4), run on SDS-PA

gels and transferred to a filter for Western blot analysis with POMA antiserum. The
filter was also exposed directly to X-ray film to detect 32P-labeled RNA
(Autoradiography). The arrow indicates the molecular size of Nova-1. The strong

reactivity present underneath the Nova-1 bands (lanes 1-4) is due to secondary anti
cross-reactivity with rabbit immunoglobulin G. The ~70 kDa band visible in lanes 1
3 is a protein related to Nova-2 that immunoprecipitates specifically with POMA
antisera.
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Figure 2: Nova-1 Enhances GlyRcc2 E 3 A Splicing in Heterologous Cell Lines.
(A) The GlyRa2 minigene used for splicing assays in transiently transfected cells
contains the complete GlyRa2 E2, a shortened intron 2, the complete genomic sequence
surrounding E3A and E3B, a shortened intron 3, and 233 nucleotides at the 5' end of E4. The
UCAU Nova-1 binding site in intron 2 is indicated by the schematic hairpin loop, and the UAAU
mutant minigene is indicated by an X.
(B) Nova-1-dependent effects on E3A splicing of the wild-type UCAU and mutant
UAAU GlyRa2 minigenes. RNA from N2A cells transfected with the wild-type or mutant
GlyRa2 minigene and the indicated amount of pcNova-1 plasmid were analyzed as in Figure 3 A.
(C) Western blot using anti-T7 antibody showing the titration of T7-tagged Nova protein
levels after N2A cells were cotransfected with the GlyRa2 minigene and the indicated amounts
of pcNova-1.
(D) Nova increases the ratio of E3A/E3B splicing from wild-type GlyRcc2 pre-mRNA,
but this effect is abrogated in the GlyRct2 mutant UAAU pre-mRNA. Three independent
transfections were performed in which splicing products (E3A or E3B) were quantitated as in
Figure 3A. Increasing amounts of pcNova-1 were cotransfected with either the wild type or
mutant GIyRa2 minigene, as indicated. Results are displayed as a ratio of E3A/E3B. The total

amount of spliced product is unchanged as a result of Nova titration; the increase in E3A usa
accompanied by a compensatory decrease in E3B utilization (data not shown). Results shown are
the average of three independent transfections, and error bars represent standard deviation.
(E and F) Nova facilitates E3A splicing in HeLa (E) and 293T (F) cells specifically in
wild-type UCAU GlyRa2 transcripts. Western blot confirmed that HeLa and 293T cells did not

express Nova and that Nova transfection led to linear increases in Nova protein (data not sho
Results are the average of two (E) and four (F) independent transfections.
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Figure 3: Scheme of purification of recombinant Nova-1:
(A) Recombinant Nova-1 fused to a C-terminal poly-Histidine tag and a Nterminal T7 tag was purified from transformed E.Coli through three affinity steps:
column, followed by anti T7 affinity column, and a ribohomopolymer column. Lane 1:
aliquot of the bacterial lysate. Lane 2: the eluted material from the Ni++ column;
the flow-through from the Ni++ column. An almost pure Nova was obtained by anti-T7

affinity chromatography (lane 4), and it was further purified and concentrated by t
binding to ribohomopolymer affinity step (lane 5).
(B) Nitrocellulose filter binding assays were performed using Nova-1 fusion
protein eluted from the ribohomopolymer column in 0.25 M NaCl and dialyzed against

buffer D. GABA= in vitro transcribed RNA corresponding to the 150 nucleotides regio
of GABAARy2 intron 8 surrounding the Nova-dependent intronic splicing enhancer
(Dredge and Darnell, in press). Globin= RNA derived from human P-Globin which spans
a 150 nucleotides region of exon 1 and intron 1, and contains no YCAY motifs.
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Figure 4: Nova-1 regulates alternative splicing in vitro:
(A) 32P-labeled RNA products and intermediates of a splicing reaction in HeLa
nuclear extract displayed on 8% denaturing gel. The reaction was carried out for 4 hrs in
the presence of 0 (lanes 1, 2, 6), 0.06 (lanes 3 and 7), 0.12 (lanes 4 and 8) and 0.25 uM
(lanes 5 and 9) recombinant Nova. The substrates, indicated on the top of the gel as WT
and mut, are GABA/Globin 2 and GABA/Globin 2 mut (see panel B), body labeled with
32P-otUTP. The identity of the indicated bands was established by RT PCR, cloning and
sequencing. The red star indicates the lariat characterized in detail in figure 6.
(B) GABA/Globin 2 substrate. The indicated cytidine residues were mutated to
adenosine in the GABA/Globin 2 mut substrate.
(C) Quantification of three different experiments performed on different days with
different preparations of the substrates. The concentration of recombinant Nova is plotted
in the x-axis; the ratio between the long and the short form normalized for the ratio
observed in absence of added Nova is plotted in the y-axis. The red bars represent the
ratio between the long and the short products in reaction containing the wild type
substrate, the blue bars represent the same ratio in reactions containing the mutant
substrate. The error bars represent standard deviations.
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Figure 5: Formation of Prominent Nova-dependent products of splicing in vitro:
(A) Schematic of the substrates used for in vitro splicing reactions. GABA/Globin 1
and GABA/Globin 2 only differ for 44 nucleotides of GABAARy2 intron 8
inserted in a globin-based backbone.
(B) In vitro splicing reactions as in figure 4A using GABA/Globin 1 and
GABA/Globin 2 as substrates. The stars indicate the bands from which RNA was
eluted and analyzed in de-branching assay (see figure 6). The color code of the
stars is the same as in figure 6.
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Figure 6: Characterization of Lariat Products:
(A) Debranching assay in HeLa cell S100 extract. The indicated bands (color code as in

figure 5B) were incubated in S100 extract (lanes 2, 4, 6, 8, 10, 12) or buffer D (lanes 1, 3,

5, 7, 9, 11). lanes 1 and 2: unspliced RNA 2, lanes 3 and 4: lariat product 2, lanes 5 and 6:

unspliced substrate 1, lanes 7 and 8: lariat product 1, lanes 9 and 10: long lariat (cassett
exon-skipping) 2, lanes 11 and 12: long lariat 1.
(B) Mapping of the branch site by primer extension. A reverse transcription reaction was
primed by a 32P-labelled oligonucleotide complementary to the 3'splice site and
polypyrimidine tract of the second intron. The presence of a branching site interrupts the
reverse transcription. Dideoxynucleotides were included in the RT mix in lanes 1, 2, 3, 4
to produce a sequencing ladder. Lane 5, lariat product from 2 substrate, lane 6, unspliced
2 substrate, lane 7, unspliced 1 substrate, lane 8, lariat product from 1 substrate.
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Figure 7:

Nova-1 interacts with component of the splicing machinery.

(A) Nova-1 and Nova-2 interactions with splicing factors. Nova-1 and Nova-2 bait
constructs were used to screen a group of splicing factors prey constructs (a kind

David Elliot, Medical Research Council, Edinburgh). Colonies were screened for growt
in medium lacking Histidine and X-gal assay.
(B) Co-immunoprecipitation assay from 293T cells co-transfected with constructs
encoding Nova-1, HuD, U2AF65, Ul 70K, SRp40, SRp20 fused to a N-terminal GST,
and constructs encoding two isoforms of Nova-1 (with and without the 24 amino acid

insertions encoded by the alternative exon H) fused to a flag tag. After cell-lysis

protein complexes were precipitated with Glutathione-coated beads, washed several t

and analyzed by western blot with anti-flag monoclonal antibody, but for the top pa
which was probed with anti-GST antibody.
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Figure 8: Immunoprecipitation from in vitro splicing reactions:
(A) Splicing reactions employing GABA/Globin construct 2 (lanes 1-4 and 9-12) and
GABA/Globin construct 2 mutant (lanes 5-8) were incubated for 4 hrs at 30°C. At the

end of the incubation, the indicated antibodies immobilized on protein A-beads were

added, and the reactions were rocked for 1 hr. After three washes, the bound RNA wa
extracted and analyzed on a denaturing gel.
(B) Enrichment of long product of splicing in the Nova pellet. The ratio long
product/short product were measured in the immunoprecipitated pellets with anti T7
anti Sm, and normalized to the same ratio in the input.
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Introduction: Role of K H domain-containing R N A binding proteins in translation:
It has been known for some time that several hnRNP proteins and SR proteins

shuttle between the nucleus and the cytoplasm (Caceres et al., 1998; Pinol-Roma and

Dreyfuss, 1992). These findings, and the discovery of the exon junction complex, prim
a series of studies aiming to demonstrate a connection between the nuclear history
the fate of messages in the cytoplasm (Dreyfuss et al., 2002; Keene and Tenenbaum,
2002; Matsumoto et al., 1998; Shyu and Wilkinson, 2000; Tenenbaum et al., 2000). Nova

has been shown to be present both in the nucleus and in the cytoplasm in brain sect

and in primary neurons in culture (Buckanovich et al., 1993; Buckanovich et al., 19
Yang et al., 1998), and a Leucine-rich region resembling a NES domain is present in
Nova-1 and Nova-2.
Nova is closely related to three shuttling hnRNPs, hnRNP K, El and E2, which

have been shown to play a role in the cytoplasmic fate of their RNA targets. HnRNP K
represses the translation of 15-lipoxygenase (LOX), a key enzyme involved in

mitochondrial membrane breakdown during erythroid cell differentiation. The expressi

of this enzyme, which is potentially extremely toxic in normal cells, must be tightl

regulated during the course of erythroid cell maturation, while the cell is still re

its mitochondria for energy, before it is released in the peripheral blood to become
reticulocyte and erythrocyte. Such control is achieved through the binding of hnRNP
and El, 2 to an UC-rich element (CCUCUU repeats) in the 3'UTR of the LOX message,
called Differentiation-Control Element (DICE). The binding of hnRNP K to the 3'UTR
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masks the message from the translational apparatus. In particular, h n R N P K bound to

DICE has been shown to inhibit the assembly of the two subunits of the ribosome at t

5' end of the mRNA, in a process that presumably involves the circularization of the
message (Ostareck et al., 2001; Ostareck et al., 1997). Interestingly, hnRNP E (also

called ctCP) is also implicated in stabilization and, ultimately, increased expressi

different message, a-globin, through the binding to a C-rich motif present in the 3
The protein is found to be part of the RNP "cc-complex", which is compatible with
efficient polysome loading and active translation (Ji et al., 2003). Other KH-domain

containing proteins have been implicated in translational control and have been foun
be associated with polysomes. FMRP, the product of the gene responsible for most

Fragile X chromosome Mental Retardation cases, is associated with polysomes in sever

cell lines (Khandjian et al., 1996), while some of the cellular FMRP seems to be par

pre-polysomal mRNPS (Feng et al., 1997). More recent studies have defined a restrict
subset of FMRP-targeted mRNAs and further demonstrated that the absence of FMRP

results in an increase and a decrease of two distinct subsets of mRNAs in the active

translating polysome fraction (Brown et al., 2001; Darnell et al., 2001). The results

Brown et al. suggest that FMRP controls some aspect of translation, although the pre
mechanism of such regulation is entirely undefined at the moment. Other, less well
characterized KH-domain containing proteins, like SCP 160 in S. cerevisiae and CRDBP, a protein that binds to the c-myc coding region, have also been shown to be
associated with polysomes (Doyle et al., 1998; Lang et al, 2001)
A clue on the potential cytoplasmic role of Nova came from the results of a

"transcribed sequence selection" (TSS) experiment in which recombinant Nova was used
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to select target sequences out of a pool of transcribed R N A s (Jensen and Darnell,
unpublished). Among other target sequences isolated with this approach, there was a

distinct population of transcribed RNAs containing a 50 bp stretch of RNA present i
domain IV of 28S ribosomal RNA. Domain IV is one of the most exposed sequences

found in 28S rRNA and in the intact 60S ribosomal subunit, as determined by chemical

probing and X-ray diffraction crystallography (Ban et al., 2000; Holmberg et al., 19

Holmberg et al., 1994b), and it is therefore likely to be accessible to protein bind

vivo. Immunocytochemical studies performed in brain slices and in primary neurons ha
shown that Nova distributes in the cytoplasm in rather discrete granules that are

heterogeneous in size. Partial co-localization of Nova and P0 ribosomal protein in t
cytoplasm and dendrites was observed (Triller and Darnell, unpublished).

Nova distribution on linear density gradients:
To gain insight into the function of Nova in the cytoplasm, we fractionated post-

mitochondrial cytoplasmic extracts on linear density gradients. We analyzed cytoplas

extract from N2A and PI9, two cell lines that express Nova, and from spinal cords an

hindbrain of mice at different ages. The profile of sedimentation of Nova-containing

structures shows some variability between cell lines and tissue, and between extract

from tissues at different ages. In N2a cells (Fig. 9) and in P19 cells differentiate

neuron-like phenotype with retinoic acid (not shown), 50% of Nova was found in the f

two fractions of the gradient, probably corresponding to protein not engaged in larg

complexes. 70% of the total content of Nova, as estimated by densitometry, sediments

fractions lighter then those containing the 80S ribosomal monomer (fractions 1 to 8
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only very small amounts are seen in the fractions corresponding to polyribosomes. The
treatment of the extracts with 30 mM EDTA, which results in the disruption of
polysomes (right panel of figure 9), did not change the profile of sedimentation of

nor did treatment with RNAse A (not shown). These data show that in the cytoplasm of

the analyzed cell lines, most Nova is not engaged in the formation of large complexe
a control, the same blots were re-probed with a monoclonal antibody against FMRP, a

protein known to be largely associated with polysomes in various cell lines (Feng e

1997; Khandjian et al., 1996). As shown in figure 9, a considerable fraction of FMRP

(36% as estimated by densitometry) associates with polyribosomes (fractions 13 thro

18); the disruption of the polysomes by 30 mM EDTA treatment results in a sizable s
of FMRP to the upper half of the gradient (figure 9, right panel).
Most of the observations that suggested co-localization of Nova and P0 ribosomal
protein were obtained in primary neurons, and increased co-localization and more
discrete Nova-positive granules were observed after three to four weeks in culture

and Darnell, unpublished). Therefore, we analyzed the distribution of Nova on linear

density gradients in neural tissue from animals at three (P3), fourteen (P14) and t

days (P30) of age. The tissue was obtained from spinal cord and hindbrain, where Nov

is the predominant Nova species. After homogenization, nuclei and non-lysed cells we

removed by a low speed centrifugation step. The supernatant was further fractionated

with a higher speed centrifugation step (20,000Xg, 10 min) to obtain a pellet enrich

vesicles of the rough endoplasmic reticulum, as shown by the staining with an antib

against Riboferin I (Fig. IOC) a transmembrane glycoprotein specifically associated

the rough endoplasmic reticulum (Kelleher and Gilmore, 1997; Silberstein et al., 1992
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Nova is more than three times more abundant in the supernatant than in the pellet
obtained in this centrifugation step (Fig. IOC). Vesicles were solubilized with

deoxycholic acid, and residual insoluble structures were discharged through a furthe

centrifugation step. The supernatants were then fractionated on linear density gradi
When the supernatant of the 20,000Xg centrifugation (S) was analyzed by linear

density gradient, a large fraction of Nova (around 40% of the total, by densitometry

sediments in the first two fractions, corresponding to the lysate layered on the top

gradient (Fig.lOA). This fraction probably corresponds to monomeric Nova, or Nova no
engaged in large complexes. 78% of the total amount of Nova sediments above the 80S
ribosome (Fig.lOA). The treatment with 30 mM EDTA does not result in a major change

of the Nova profile of sedimentation (Fig. 10A, right panel), although it does cause

of the ribosomes from the bottom part of the gradient to the upper part, following t

disruption of the polysomes (Fig. 10A, P0 lane, right panel). When we analyzed the Pe
(P) of the 20,000Xg centrifugation, a smaller fraction of Nova was found in the top

fractions of the gradient, not surprisingly, since the majority of the proteins that

part of large complexes are expected to be found in the S fraction. Around 50% of th
Nova reactivity is found in the fractions above the 80S ribosome monomer, and 20%

sediments in the lower part of the gradient, in the fractions where polysomes are fo
(Fig.lOB). Again, the treatment with 30 mM EDTA does not dramatically modify the
overall distribution of Nova on the gradient.
The analysis of extracts from fourteen day old animals shows a similar profile,
with around 60% of Nova found in fractions above the 80S, and 20% of Nova in the
polysomal fractions, in both supernatant and pellet fractions (data not shown).
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In one month old animals, a fraction of Nova variable between 17 and 3 0 % of the
total (in the supernatant and pellet fractions, respectively), is found to sediment

lower part of the gradient (fractions 13 to 18, polysomal fractions). EDTA treatment
shifts 77% of the pool of Nova associated with polysomes (from 17.4% of the total

reactivity for Nova by densitometry to 3.9% in the "free" polysomes fraction) to the
upper part of the gradient, coincidentally with the expected shift of the ribosomes
detected with the anti-PO serum (Fig. 1 IA and C).
As a comparison, we stained the same blots with a human polyclonal antibody

against Hu (Okano and Darnell, 1997). The pattern of sedimentation of Hu proteins in

gradients of Accudenz and Glycerol has been characterized in various tumor cell line
neural origin (Antic and Keene, 1998). While some of the cytoplasmic Hu is found in
free state, a variable amount is engaged in the formation of large heterogeneous

ribonudeoprotein complexes (a complexes), and around twenty per cent of the total is

associated with polysomes (|3 complexes)(Antic and Keene, 1998). In our tissue extrac

the distribution of Hu reactivity matches quite closely the distribution of Nova. At

most of Hu is part of large, heterogeneous complexes, that coincide with the a compl
described in previous studies (Antic and Keene, 1998), and the treatment with EDTA

only marginally modifies the pattern of sedimentation. At P30 more than twenty perce
of the Hu sediments in the denser part of the gradient and the treatment with EDTA

determines a shift to less dense fraction, coincidentally with the disruption of pol
(Fig. HAtoB).
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Changes in the level of expression of genes in the absence of Nova:

In an attempt to expand our understanding of the variations in gene expression under
the Nova null phenotype, mRNAs from mutant animals and their wild-type or

heterozygote littermates were purified and utilized to probe microarrays. The positi

a given mRNA in a linear density gradient can be attributed to the number of associa

ribosomes. The number of ribosomes per mRNA reflects the translational efficiency of

the mRNA, unless the ribosomes are stalled or translation is inhibited in the elonga

phase. An mRNA that is poorly or not translated will typically accumulate in the mRN
or "monosome" (80S) fraction of the gradient; translationally active mRNAs will
sediment in the polysome fraction (reviewed by Carter, M.S. et al., 2000). To

specifically identify differences at the translational level, we compared absolute l
mRNAs and abundance of mRNA specifically in the polysome fraction. For each

experiment, post-mitochondrial supernatant obtained from four pooled spinal cords an
hindbrains was fractionated on a linear 20 to 50% sucrose gradient and the mRNA

associated with each fraction was purified (Fig. 12A). One fifth of the total volume

extract was not fractionated; mRNA was directly purified as the "total" fraction. Th
purified mRNA from the input and polysome fractions was utilized to generate cDNA

first, using an oligo(dT) containing the T7 promoter sequence as primer, which allow

further transcription step in presence of biotinylated nucleotides to generate the c
used to probe the microchips (Fig. 12B). We probed the three Affymetrix Murine
Genome Array U74 chips covering approximately 36,000 full-length mouse cDNAs and
EST clusters from the UniGene database (www.affymetrix.com). The experiment was
repeated three times, resulting in three intensity values for each gene represented
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chips for the total (mutant and wild type) and three intensity values for the polysomes
fraction (mutant and wild type).
We first verified the efficacy of our fractionation procedure by comparing the
abundance of mRNAs in the total fraction (independently of the genotype) with the

polysome fraction. We performed a t-test analysis between the pool of six values of

total fraction (three wild type and three mutant) and the corresponding six values o

polysome fraction for each gene represented in the chips, using GeneSpring 5.0 softw

(Silicon Genetics) (Fig. 13). A number of genes appear to be more abundant in the to
than in the polysome fraction. Ten cDNAs, among which glyceraldehyde-3-phosphate

dehydrogenase and beta actin, are enriched in the polysomes, consistently with a hig

rate of translation. A number of cDNAs encoding ribosomal proteins are two to four f

more abundant in the total fraction than in the polysomes, consistently with previou

findings (Table I)(reviewed in Meyuhas and Hornstein, 2000). mRNAs encoding ferritin,

whose expression is also regulated at the level of translation, were similarly distr
To compare differences specifically in the polysome fractions between wild-type

and Nova-null mice, the set of values corresponding to the polysome-associated mRNAs

was normalized to the corresponding set of values obtained with the total probe. A r

analysis detected statistical differences between the two sets of polysome-associate
mRNAs normalized to their corresponding input values. The intensity of sixty-seven

genes that showed equivalent level in the total fraction was statistically different

wild-type and mutant polysomes (p<0.05) (Fig. 14). These genes were grouped into two
groups based on whether they were decreased or increased in the polysomes of Nova-1

null mice. Thirty-nine messengers were found to be less represented in the pool of t
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polysome-associated m R N A s from Nova-null mice (table II), while twenty eight were
increased (table III).

Discussion:
Several RNA binding proteins are found both in the nucleus and in the cytoplasm
and play different roles in RNA metabolism in the two compartments (reviewed in
(Dreyfuss et al., 2002). In an attempt to understand the function of the cytoplasmic

of Nova, we began the characterization of the cytoplasmic complexes that contain the

protein. Our results show that an amount of Nova variable between cell lines and tis

from animals of different ages is involved in large heterogeneous complexes, which a

stable in presence of EDTA. Only in extract from animals older than three weeks, aro

one fifth of the total amount of Nova detected by western blot sediments in the same

fractions as polyribosomes formed by four or more ribosomes, and it is shifted to le

dense fractions in response to EDTA treatment. The size of these later complexes and

their dependence on divalent cations suggest that they represent Nova associated wit
polyribosomes.
The large heterogeneous complexes containing Nova, not dependent on divalent
cations, as shown by their resistance to EDTA treatment, are reminiscent of the a-

complexes containing FMRP, Hu or aCP (Antic and Keene, 1998; Feng et al., 1997; Ji e

al., 2003). These complexes are described as mRNPs, but their exact composition and t

relationship between proteins and RNA within them are largely unknown. It is postula
that mRNAs are tightly packed with protein components of the mRNPs, since the

complexes are completely or partially resistant to RNAse treatment (Ch'ng et al., 19
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Feng et al., 1997; Herrera et al., 1988), and very prolonged treatments with R N A s e are
required for their disruption (Antic and Keene, 1998). Treatments with RNAse A
sufficient to disrupt the polyribosomes did not result in shift of the Nova complex

dense fractions (data not shown), suggesting that either the Nova-positive complexes

observed do not contain RNA, or that the RNA contained in them is not exposed to the
RNAse action. Since we have evidence that Nova is associated with poly(A)+ RNA in
the cytoplasm (Triller and Darnell, Dunne and Darnell, unpublished) we are inclined

consider the second explanation as more probable, although the possibility that Nova
be engaged in large complexes not containing RNA can not be disregarded.
Most of the studies aimed to characterize the cellular structures RNA binding
proteins are engaged in, such as mRNPs and polyribosomes, have been conducted in
immortalized cell lines, rather than in extracts from differentiated tissues. Given
complex relationships between mechanism of gene expression, cell cycle and

differentiation, it is not surprising that RNA binding proteins are part of complexe

different size and functional state across different cell lines and tissues. The dif
the Nova sedimentation pattern we observed between neuroblastoma cells and spinal

chord tissue, and between spinal chord tissues of different ages, may underlie chang

functional roles of Nova in various physiological states. The heterogeneous structur

which most of Nova is engaged could represent sites of storage or transport of mRNAs

whose translation requires a tight regulation in time or in space. The later associa

some Nova with polyribosomes could be due to the activation of the translation of so

of the mRNAs Nova is bound to, possibly as a consequence of some maturation event in
the nervous system.
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H u is a family of four R N A binding proteins found in the nucleus and cytoplasm.

HuA(also called R) is ubiquitously expressed, while HuB, HuC, and HuD are exclusive

expressed in neurons. A role in regulation of alternative splicing have been demonst
for their Drosophila homolog ELAV1 (Koushika et al, 1996; Koushika et al., 2000;

Lisbin et al., 2001). Hu family members bind poly(A)+ RNA in the cytoplasm (Gallouzi
et al., 2000; Gao and Keene, 1996). Described cytoplasmic Hu functions include
stabilization of messages containing AU-rich elements (ARE) in their 3'UTR, and

stimulation of translation of specific messages (Antic et al., 1999; Brennan and Ste
2001; Fan and Steitz, 1998). Hu has consistently been found to be engaged in
heterogeneous mRNPs in several cell lines, and to be associated with polysomes in a
proportion variable on the cell type (Antic and Keene, 1998; Gallouzi et al., 2000;

and Keene, 1996). We report the first analysis of the Hu sedimentation in CNS extract

Interestingly, the pattern of sedimentation of Hu in spinal chord and hindbrain ext
matches closely the one of Nova: Hu sediments with large heterogeneous structures,
presumably mRNPs, throughout the development time points we analyzed, and some Hu

is found in the polysome fractions, most visibly in extracts from one month or older
animals. Hu has been found to form with Nova an RNAse-resistant complex (Okano and
Darnell, unpublished, and Fig. 7B). It is therefore possible that in spinal chord
cytoplasmic extracts, Hu and Nova are present in the same mRNP and regulate the
expression of an overlapping set of messages.
We utilized the fractionation of cytoplasmic extracts from neural tissue on linear

density gradients to begin to identify genes whose translational state is changed i

absence of Nova-1. While a similar approach has been utilized to analyze extracts fr
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cerevisiae and a number of replicating cell lines (Arava et al., 2003; Brown et al., 2001;

Galban et al., 2003; Grolleau et al, 2002; Johannes et al., 1999; Zong et al., 1999),

the first such analysis on extracts from fully differentiated neural tissue. This st

of obvious relevance for the study of aspects of translation that are thought to be

of mature neurons, such as dendritic translation. The reliability of our data set wa
validated by the finding that several mRNAs encoding ribosomal proteins were found
decreased in the polysome fraction compared to the total. The synthesis of many

mammalian ribosomal proteins has been shown to be selectively regulated in a growth-

dependent manner at the translational level. The corresponding mRNAs are characteriz

by the presence of a 5'-terminal oligopyrimidine tract (5TOP) and therefore are ref
to as TOP mRNAs. The proportion of TOP mRNAs actively engaged in protein

synthesis, and therefore associated with polysomes, is significantly lower than that

characteristic of other ubiquitous mRNAs in cells that cease to divide, as most of t

in the spinal cord, than in actively replicating cells (reviewed by Meyuhas and Horn
2000).
We identified sixty-seven genes whose distribution in the polysomes is increased
or decreased in response to the ablation of Nova. Although further experiments are

required to verify that the observed shift of mRNAs in the linear gradient reflects

of protein synthesis, the identity of some of the messengers identified with this ap
provides some clues on cellular functions that are altered as a direct or indirect

consequence of the deletion of Nova. The described functions of a group of six genes
four of which are decreased in absence of Nova, and two increased, can be loosely

referred to the mechanisms connecting receptors and cytoskeleton in the post-synapt
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densities through clustering molecules and the signalling cascades mediated by ras
monomeric GTPases. CNK (connector enhancer of ksr) has been originally described in

Drosophila as a modifier of Kinase suppressor of ras (ksr), a required component with
the RAS/MAPK cascade (Therrien et al., 1998)). CNK is a large protein containing a

variety of potential protein-protein interaction modules: a sterile alpha motif (SAM
domain, a PDZ domain, a pleckstrin homology domain (PH), a so-called CRIC domain

(Conserved Region in CNK) two proline-rich stretches that fit the consensus for SH3
domain binding site, and several potential tyrosine phosphorylation sites (Therrien

1998). It has been proposed to act as a multiadaptor molecule by binding and probably
inhibiting RAF (MAPKKK) while enhancing Ras signaling in Drosophila (Therrien et
al., 1999). Studies in rat have shown that Maguin, the rat homolog of CNK, interacts

Postsynaptic density PSD-95 (SAP 90), a major component of the post-synaptic densit

with a role in clustering receptors and channels and in signal transduction (Yao et
1999). Interestingly, the level of mRNA encoding DAP-1 (GKAP), a highly brainenriched protein also known to form a complex with PSD-95 (Kim et al., 1997; Satoh
al., 1997), is decreased in the polysome fraction of the Nova-null animals. mRNAs
encoding Rho GTPase activating protein 6 and ras-j were also decreased in the
polysomes in the absence of Nova. Members of the Ras family of monomeric GTPases

play a major role in the signal transduction from receptors associated with post-sy
density. SynGAP is associated with PSD-95 in many glutamatergic synapses, citron (a

rho/rac effector protein), and synaptic gpl30 Ras GAP have been the detected as part
post-synaptic densities (Kennedy, 1998; Kennedy, 2000). Furthermore, regulation of
remodeling of the actin cytoskeleton by Rho GTPases is essential for the formation
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post-synaptic specializations, like dendritic spines, and yet another protein encoded by

one of the mRNAs whose distribution is modified in the absence of Nova, filamin, pla

a crucial role in the modulation of the functional proprieties of filamentous actin

dendritic spines (van der Flier and Sonnenberg, 2001). The simultaneous alteration of
distribution on polysomes of messengers encoding functionally related proteins in

response to the absence of Nova suggests that disruption of organization of post-sy

densities or dendritic spines, through alteration of the clustering complexes or the
mediated pathways may be implicated in aspects of the Nova-1-null phenotype.
Simultaneous changes of abundance in the polysomes are also observed for a
group of three mRNAs encoding metalloproteases, and three mRNAs encoding

transcription factors. No obvious functional relationship is evident among the membe
these two groups.
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Figure 9: Analysis of cytoplasmic extracts from N 2 a cells on linear density
gradients:

A cytoplasmic extract from N2a cells was analyzed by sedimentation on a linear dens
gradient.

For (A) and (B), the top panel shows the absorption profile of a 20%-50% (w/w) sucro

gradient at 254 nm, with major ribosomal peaks indicated; the bottom panel shows th

distribution of Nova, FMRP and ribosomal protein PO in correlation to the sedimentat
profile. Fraction numbers are indicated underneath the corresponding lanes.
(A) The cytopasmic extract was prepared and sedimented in the presence of 5 mM
MgCl2.
(B) Polysomes and ribosome monomers are disrupted by EDTA.
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Figure 10: Analysis of polysomes from P3 spinal cords and hindbrains.
Spinal cords and hindbrains from P3 animals were homogenized and a cytoplasmic

extract was extracted. After eliminating nuclei with a low speed centrifugation, th

extract was fractionated by centrifugation at 20,000 X g yielding a supernatant ("

fraction and a pellet enriched in rough endoplasmic reticulum. The pellet was solub

("bound") with deoxycholic acid, and both fractions were analyzed by centrifugatio
linear density gradient.
(A) Western blot analysis of the collected fractions of the sucrose gradient where
"free" fraction was loaded. Antibodies against Nova, Hu, P0 were employed.
(B) Western blot analysis of the collected fractions of the sucrose gradient where
"bound" fraction was loaded. Antibodies against Nova, Hu, P0 were employed.
(C) An aliquot of the "free" and "bound" fraction was analyzed by western blot with

antibody against ribophorin, a marker of the endoplasmic reticulum, and antibody ag
Nova.
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Figure 11: Analysis of polysomes from P30 spinal cords and hindbrains.

Extracts from spinal cords and hindbrains of P30 animals were prepared as in figure
and analyzed on linear density gradient as described.
(A) Analysis of the "free" polysomes.
(B) Anlysis of the "bound" polysomes.

(C) Quantification by densitometry of the bands reactive to Nova in western blot of

density gradient fractions shown in (A). The blue bars indicate the values of the M
fractions, the red bars indicate the EDTA fractions.
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Figure 12: Scheme of the analysis of the polysome-associated m R N A s in wild type
and Nova-null mice:

(A) Sucrose gradient fractionation of total cytoplasmic extracts from P7 spinal cor
brainstem. The top panel shows the absorption profile of the sucrose gradient. The

polysome fractions are indicated. The bottom four panels show the distribution of N

and PO ribosomal protein by Western analysis of the fractions from two sucrose grad
on which extracts from wild type and Nova-1 null tissues were loaded. The residual
bands reacting with the anti-Nova antibody in the KO row correspond to Nova-2.

Fraction numbers are indicated below the corresponding lanes, and fractions 9-11, us
for microarray analysis, are underlined.

(B) Synthesis of the biotinilated probes for Affymatrix microchips hybridization. T

RNA collected from the indicated fractions or from the total was reverse transcribe
using primers containing a stretch of oligo(dT) at their 3' end and a T7 promoter
sequence at their 5'end. The cDNA resulting from this reaction is then transcribed

T7 promoter in presence of Biotin, producing the biotinilated cRNA probe that is us
the hybridization of the microarrays.
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Figure 13: Comparison between the total and polysome fraction (validation of the
fractionation procedure):

Four sets of intensity values were obtained for each gene from the hybridization of
microarrays. Each set is defined by Genotype and Fraction (WT tot, KO total, WT

polysomes, KO polysomes), and contains three intensity values (replicates) per gene.

the comparison between total and polysome fractions, shown in this figure, the sets

pooled by Fraction. Therefore, two sets (Total and Polysome) with six values of int

each to each gene correspond. A Mest was run between the Total and the Polysome set

for each gene. The graph shows the intensities of those genes for which the two set

values (total and polysome) were found to be different (p<0.001). The y-axis repres

the intensity values expressed in logarithmic scale, normalized by the mean intensi

each chip. The x-axis lists the four experimental conditions. For each gene, a colo

joins the four intensity values (each of which is the mean of three replicates) acr
four experimental conditions.
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Replicates:

W T Total

KO Total

WT Polysomes

KO Polysomes

Table I:
List of genes that show different relative intensity in the Polysome fraction and the Total
(p<0.001). Yellow rows indicate genes encoding ribosomal proteins. Light blue rows
indicate genes encoding ferritin.
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LESS ABUNDANT IN THE POLYSOME FRACTION THAN IN THE TOTAL
protein tyrosine phosphatase 4a3
Mus musculus, clone IMAGE: 1379146. mRNA, partial cds
ribosomal protein S12
qrowth arrest specific 5. encodes U75 and U76 snoRNAs
t-complex testis expressed 1, dvneln llqht chain (microtubule associated transport)
ribosomal protein L41
RIKEN cDNA 3200001M24 qene
epimorphln
unknown;
svnapsin I actin bindlnq synaptic vesicle
translocase of Inner mitochondrial membrane 9 homoloq (yeast)
RIKEN cDNA 2400008104 qene
hexokinase 1, deficiency causes hemolytic anemia
ribosomal protein S26
RIKEN cDNA 2900010M23 qene
thymosin, beta 10
ESTs, Weakly similar to RIKEN cDNA 2010000G05
Mus musculus. Similar to chromosome 9 open readinq frame 16, clone MGC: 19388
ribosomal protein L27a
RIKEN cDNA 3110005M08 qene
ribosomal protein L28
ESTs
DIGeorqe syndrome critical reqlon qene 6, development, schizophrenia
cyclin I
ribosomal protein S28
Mouse qene for ferritin H subunit.
neuronatln, exp In neonates>adults, expressed in VP cells of rat supraoptic nucleus
SEC61, qamma subunit (S. cerevisiae)
vesicle transport throuqh interaction with t-SNAREs lb homoloq
RIKEN cDNA 4922501H04 qene
thymosin beta 4
ribosomal protein, larqe, PI
ribosomal protein L31
Mus musculus qene for ribosomal protein L27A. complete cds.
RIKEN cDNA 2310022M17 qene
ribosomal protein S8
small nuclear ribonudeoprotein polypeptide G
RIKEN cDNA 1010001M12 qene
Mus musculus, quanine nucleotide bindlnq protein (G protein), qamma 5, clone MGC:
ferritin heavy chain
Mus musculus, ribosomal protein L23a, clone IMAGE:4988735, mRNA, partial cds
Purklnle cell protein 4
ribosomal protein Sll
S100 calcium bindlnq protein Al
GTP cyclohvdrolase 1
RIKEN CDNA 2410089B13 qene
Mus musculus ferritin L-subunit qene exons 1-4, complete cds.
ESTs
RIKEN CDNA 2310040A07 qene
RIKEN CDNA 1110060M21 qene
qamma-amtnobutvric acid receptor associated protein
RIKEN CDNA 2810004N20 qene
monocyte to macrophaqe differentiation-associated
deformed epidermal autorequlatory factor 1 (Drosophila)
DNA seqment. Chr 2. ERATO Dol 217, expressed
Cluster Incl AF100956:Mus musculus major histocompatibility locus class II reqion
RIKEN CDNA C330016H24 qene
ribosomal protein S17
RIKEN cDNA 4933439F18 qene
RIKEN CDNA 1810037117 qene
ESTs
Mus musculus, Similar to hypothetical protein FU21079,
67kD, ribosomal protein
Mouse ribosomal protein L30 qene, complete cds.
RIKEN cDNA 2900074C18 qene
RIKEN CDNA 3110038K10 qene
cadherln 11, alternatively spliced
Mus musculus, clone IMAGE:4504748, m R N A
RIKEN cDNA 0610010E21 qene
acidic ribosomal phosphoprotein PO
RIKEN cDNA 2410088K19 qene
RIKEN cDNA 2210013021 qene
ribosomal protein L13
mitochondrial ribosomal protein L52
ESTs
ribosomal protein S2
expressed sequence AI463719
RIKEN cDNA C530005M16 qene
protein kinase Inhibitor, qamma
NADH dehvdrooenase (ubiquinone) 1 alpha subcomplex 2
ESTs, Hlqhlv similar to N U M M MOUSE NADH-ublqulnone oxldoreductase 13 kDa-A
RIKEN cDNA 2010003014 qene
MORE ABUNDANT IN THE POLYSOME FRACTION THAN IN THE TOTAL
protein kinase C, lambda
RIKEN cDNA 1110007C02 qene
NADH dehydrogenase flavoprotein 1
ESTs
actin, beta, cytoplasmic
RIKEN cDNA 2210013K02 qene
qlvceraldehvde-3-phosphate dehvdrooenase
expressed sequence AW048948
RIKEN cDNA 2410015A15 qene
expressed sequence AI481191

T/P
6.12
5.35
4.58
4.46
4.45
4.39
4.31
4.27
4.13
4.07
4.04
3.96
3.94
3.78
3.62
3.62
3.54
3.34
3.29
3.27
3.15
3.13
3.12
3.07
3.04
3.04
3.04
3.02
2.99
2.97
2.87
2.86
2.83
2.82
2.82
2.81
2.75
2.71
2.69
2.69
2.66
2.62
2.61
2.61
2.57
2.55
2.50
2.50
2.49
2.48
2.47
2.46
2.45
2.42
2.40
2.39
2.39
2.37
2.36
2.35
2.30
2.29
2.28
2.28
2.27
2.26
2.25
2.24
2.23
2.19
2.18
2.18
2.18
2.16
2.16
2.12
2.10
2.10
2.09
2.07
2.02
2.00
0.70
0.69
0.66
0.61
0.60
0.59
0.54
0.54
0.51
0.38

Fig. 14: Comparison between the polysome fractions of W T

and Nova-1-null

animals: For each gene, two sets of intensity values were compared: WT polysome and
KO polysome. Each set contained three values, corresponding to the number of
replicates. The intensity values in the polysome data sets were normalized to the

corresponding values in the total data sets. The graph, with the same conventions as

figure 14, represents exclusively the genes that shown significant difference (/-t
p<0.05).
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Replicates: K O Polysomes

W T Polysomes

K O Total

W T total

Table II:
List of Genes whose intensity is at least two times higher in the Wild Type polysome
fraction normalized to Total than in the Nova-null polysome fraction (p<0.05).
Entries corresponding to genes with a described function related to post-synaptic
densities, ras/rho signaling pathways and dynamic organization of the cytoskeleton in
neurites are colored in light blue. Transcription factors are labeled in purple.
Metalloproteases are labeled in yellow.

Table III:
List of Genes whose intensity is at least two times higher in the Nova-1-null mutants
polysome fraction normalized to Total than in the Wild Type polysome fraction (p<0.05).
Color convention are the same as in Table II.
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T A B L E

II: Decreased in the P o l y s o m e Fraction of K O

(WT P/WT TV(KO P/KO T)
Name
6.13
ESTs(unknown)
5.29
EST(unknown) transcription factor?
4.79
Mouse CNK (connector enhancer of ksr)
4.3
RICKEN cDNA
4.16
Damage-induced neuronal endopeptidase (DINE)
4.01
RICKEN cDNA
3.92
cell division cycle 45 homolog -like
3.53
Rho GTPase activating protein 6
3.42
ESTs
3.38
RICKEN cDNA
3.35
ESTs
3.19
3.12
insulin like peptide?
3.07
endothelin converting enzyme 2
2.95
RICKEN cDNA
2.63
RICKEN cDNA
2.63
ESTs
2.56
Ngfi-A binding protein 1(NAB1)
2.55
helicase-like transcription factor
2.5
ADAMTS15
2.49
ras homolog gene family, member J
2.44
ESTs
2.43
ESTs
2.43
2.41
melastatin 1
2.4
ESTs
2.36
Fas-activated serine/threonine kinase
2.32
acid phosphatase 2, lysosomal
2.3
RICKEN cDNA
2.28
RICKEN cDNA
2.26
RICKEN cDNA
2.19
ESTs
2.19
RICKEN CDNA
2.19
nPAS 1
2.19
RICKEN cDNA
2.18
2.15
SPLASH (PLA2IID),phospholipase A2
2.05
ESTs(unknown)
2.04
RICKEN cDNA
similar to cleavage stimulation factor subunit 3
structural protein of Rauscher oncovirus(plO)
DAP-1
T A B L E III: Increased in the P o l y s o m e Fraction of K O
GENBANK
AV085172
AV330090
AI465103
AV092700
AV294462
AV250850
AA623482
X00686
AV378373
AW049330
AW123239
AA919877
U72059
AV094422
AW122825
AI854147
AW045678
AW045965
U62674
AI837599
AI848299
AW048995
AW120523
AA839260
AI850861
AI152936
A1585778
AI850923

Name
selenium binding protein 2
(PNKP) polynucleotide kinase 3'- phosphatase
VACM(vasopressir) activated Calcium mobilizing)
epithelial membrane protein 3
unknown
RIKEN cDNA
Similar to PDZ protein Interacting with TC10
Mouse gene for 18S rRNA.
Filamin
EST unknown
EST unknown
Putative membrane protein
chloride channel regulator Icln(pseudogene)
EST unknown
EST unknown
brain and acute leukemia (BALC) cytoplasmic
RIKEN cDNA
RIKEN cDNA
Cluster Ind
neural stem cell derived neuronal survival protein
RIKEN cDNA
clone IMAGE
EST unknown
EST unknown
EST unknown
RIKEN cDNA
EST unknown
EST unknown

TV(WTP/WTT)
9.92
5.87
4.73
4.51
3.91
3.89
3.44
3.19
3.12
2.95
2.92
2.76
2.64
2.43
2.42

2.4
2.4

2.36
2.35

2.3

2.29
2.27
2.14
2.09
2.08
2.07
2.07
2.02

p-value
0.00159
0.00332
0.04817
0.02798
0.03258
0.04257
0.00594
0.01020
0.04506
0.01594
0.04348
0.03302
0.02224
0.02317
0.03850
0.04425
0.01900
0.00563
0.04784
0.02647
0.01853
0.02088
0.04842
0.01588
0.04615
0.03946
0.03320
0.04149
0.00626
0.00620
0.01563
0.04362
0.00720
0.02959
0.02530
0.02309
0.02142
0.00987
0.02370

p-value
0.00102
0.03178
0.03356
0.03013
0.02058
0.04504
0.00351
0.03115
0.03880
0.00885
0.00041
0.04070
0.00409
0.03592
0.03813
0.00534
0.04961
0.00679
0.04245
0.03956
0.03593
0.02920
0.00425
0.00918
0.02885
0.04229
0.00915
0.00999

C h a p t e r

5:

Role of phosphorylation in control of splicing and translation in the neural system:
Phosphorylation is arguably the most frequent reversible post-translational

modification in the nervous system. Innumerable examples of reversible change of the

proprieties of a protein due to addition of a phosphate group to the hydroxyl groups

Serine, Threonine or Tyrosine have been described. In neurons, like in all cell type

phosphorylation of proteins is massively employed in signal transduction pathways th

convey information from the extra-cellular environment to the inside of the cell. De

the enormous complexity of the characterized signal transduction pathways identified
the nervous system, one can find a few themes common to the vast majority of them

(reviewed in Siegelbaum et al., 2000). In the most schematic form, all signal transdu

pathways in the CNS are initiated by an external signal or first messenger, which bi

receptor. Protein phosphorylation plays a major role in the modulation of the synapt

functions in response to the stimulation metabotropic receptors. The complex of liga
and receptor activates downstream events through the activation of another set of

molecules. Despite the great variety of molecules involved in this step, pathways of

signal transduction acting through phosphorylation can be grouped in two large group

those initiated by tyrosine kinase receptors and those initiated by G protein-couple

receptors. The receptor tyrosine kinases bind peptide ligands, mostly cytokine and g

factors. The activation of tyrosine kinase pathways results mostly in long term chan
neuronal function through changes in gene expression. G protein-coupled receptors

constitute a large family of integral proteins characterized by the presence of seve

98

transmembrane domains and by the functional coupling with guanine nucleotide-binding

proteins (G proteins). G proteins, in turn, activate or inhibit enzymes often referre
primary effectors, which produce second messengers. Second messengers transducing

signals from G protein-coupled receptors in neurons are essentially cyclic AMP, whic
activates Protein kinase A, Inositol triphosphate, Diacyl Glycerol and Ca2+, which

activate protein kinase C, and, through the activation of phospholipase A2, Arachido

Acid and its metabolites. The second messengers, in turn, trigger biochemical cascad
often involving the phosphorylation of numerous other substrates, the activation of
signaling cascades, or the mobilization of Ca2+ions from intracellular stores. The
physiologic outcome of the activation of a signal transduction pathway is often the

of the interaction with many other pathways that can converge or antagonize each oth
LTP, for example, has been shown to be affected by the protein kinase A, calcium
calmodulin kinase IV and MAP kinase cascades, all which converge in the
phosphorylation of CREB (reviewed in Barco et al, 2003).
Phosphorylation is known to play important roles in the regulation of pre-mRNA

splicing and regulation of mRNA translation. I already mentioned the role of mTOR in

synaptic plasticity (Tang et al., 2002), and the role of phosphorylation of eEF2 in t
increase of ccCaMK II synthesis in response to stimulation of the NMDA receptor

(Scheetz et al., 2000). Changes in alternative splicing have been observed in numerou

instances in intact animals in response to behavioral pattern and physiological stim

as diverse as stress, nutritional status, cocaine and ethanol abuse (reviewed in Sta

2002). In few cases, however, has the activation of a specific signaling pathway dire

been shown to be involved in the regulation of alternative splicing choices. Notably
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the neural functions, a pyrimidine-rich element has been identified, that is necessary and
sufficient to confer regulation by Ca27Calmodulin-dependent protein kinase IV (CaMK
IV). The element is found in the STREX exon of the BK potassium transcript, and the
activation of CaMK IV inhibits its inclusion, thereby likely decreasing the Ca2+
sensitivity and opening probability of the channel (Xie and Black, 2001).

Nova 1 is a phosphoprotein:
The alternative splicing of the seventy-two nucleotides long exon H is known to

generate two isoforms of Nova-1 (Buckanovich et al., 1993). Exon H encodes a domain,

that we will call domain H, characterized by its high content of serine and threonin

residues (twelve), five of which are preceded or followed by prolines, suggesting th
they may be phosphorylation sites (Fig. 15B) (Kemp and Pearson, 1990). Furthermore,

Nova-1 recognition motifs have been described in the intron downstream of exon H, an

in the exon H itself, suggesting that the alternative splicing of exon H may be regu

by Nova itself (Buckanovich and Darnell, 1997). These features suggest that exon H ma

encode a regulatory domain, whose inclusion is object of further regulation. To veri

first part of this hypothesis we tested whether Nova-1 is phosphorylated in vivo and
whether differences in the level of phosphorylation exist between the two isoforms.
Vectors encoding the two isoforms were transfected into neuroblastoma N2a cells,

radioactive inorganic phosphate was added to the medium, and the protein purified by
immunoprecipitation was analyzed by autoradiography for the incorporation of

phosphate. The isoform containing domain H is robustly phosphorylated, more than ten

times above the level of the form without the domain (Fig. 15 A and 15D). Analysis o
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sequence of the domain H shows that six residues match the consensus sequence for
phosphorylation sites by two protein kinases, protein kinase C (PKC) and Glycogen

Synthase Kinase 3 (GSK 3) (Fig. 15B). We substituted alanine residues for some of th

serine and threonine residues in various combinations by site-directed mutagenesis t
to identify the phosphorylation sites. The phosphorylation level was unchanged when
sites 5 and 6 were mutated, and was reduced to the level of the form not containing
domain H when sites 2 and 4 or 2, 5 and 6 were mutated, suggesting that site 2 is

necessary for phosphorylation (Fig. 15C). The mutation of site 2 alone to alanine wa
sufficient to reduce the intensity of phosphorylation to the level of the form not
containing domain H (Fig. 15D). These data suggest that the second serine of domain
is the only site of phosphorylation.
We have not been able to observe functional differences between the two

isoforms of Nova-1, nor between the forms generated by site-directed mutagenesis and

the wild type. Both the isoforms generated by alternative splicing are engaged in th

same set of known protein-protein interactions (Fig. 7B), and they have a similar ef
promoting the inclusion of exon 3a of the Glycine receptor minigene (Fig. 16A).

Furthermore, the mutation of the second Serine to Glutamate, which mimic a phosphate

group because of its negative charge, has the same effect on splicing of the Glycine
receptor minigene as the mutation to Alanine, which cannot be phosphorylated (Fig.
16B). Furthermore, the intracellular distribution of the two isoforms differing for
inclusion of the domain H does not show any major difference (Fig. 16C).
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Discussion:
We established that Nova 1 is a phosphoprotein, and that the phosphorylation site

is in an alternatively spliced exon. A weakly labelled band corresponding to the iso

not containing the alternative exon is observed in some of the experiments, indicati

much less utilized phosphorylation sites exist in the protein outside domain H. It i

possible that the second serine of exon H is not the only phosphorylated site, but a

whose phosphorylation is required for the phosphorylation of a second site, a mode o
phosphorylation that has been shown for Glycogen Synthetase Kinase 3 (GSK3)

substrates, for example (reviewed in (Biondi and Nebreda, 2003). We have not been abl

to detect a functional difference in the ability to regulate splicing nor in the int
localization of the isoforms differing for the alternative inclusion of exon H, nor
the mutants. We do not know at present what the functional role the phosphorylation

Nova-1 is. The H domain primary sequence, which is rich in purine, serine, threonine
matches the consensus for PEST regions as evaluated by a web-based algorithm,

PESTFind (http://www.icnet.uk/LRITu/projects/pest/). It is well established that PES

motifs serve as proteolytic signals to target the proteins for degradation by the 26
proteasome, in a process that involves phosphorylation-dependent ubiquitination
(Rechsteiner and Rogers, 1996). Although we have not directly measured the half-life

the two isoforms in a pulse-chase experiment, we have no indication that the isoform

containing exon H is less stable than the one not containing it. PEST sequences have

been demonstrated not to affect protein stability in a few instances (Chen and Clark

2002). Bicoid (Bed), a homeodomain transcription factor, is also a translational regul
of caudal in Drosophila. The binding of a Bed-binding region (BBR) in the 3'UTR of
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caudal through the homeodomain is not sufficient to achieve such regulation: a P E S T

region in Bicoid is required for the translational repression of caudal (Niessing et

1999). Furthermore, deletion of a region that includes a PEST domain in CPEB abrogat
tubulin binding in vitro and centrosome localization in vivo, suggesting that PEST
domain may mediate the interaction of CPEB with the cytoskeleton (Groisman et al.,
2000). Analogously, one can envision a scenario in which the H domain exerts an

inhibitory effect on translation of the mRNA bound to Nova, and phosphorylation coul

exert some regulatory effect, for example releasing the inhibition in response to th

activation of a signaling pathway. The interaction to the cytoskeleton, as in the CP

example, is also an interesting hypothetical scenario for the function of the H doma

since RNA granules reactive to anti-Nova antibodies have been described in dendrites
presumably carrying mRNA to intracellular destinations (Darnell and Triller,
unpublished).
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Figure 15: Nova-1 is phosphorylated in a domain encoded by cassette exon H :
(A) Comparison between the level of phosphorylation of Nova-1 H+ and Nova-1 H- in
N2a cells. Cells were transfected with constructs encoding the two isoforms tagged
T7, and inorganic 32P was added to the medium. After 5 hrs incubation, cells were
harvested, lysated and and immunoprecipitated. The pellet was treated with RNase A
15 minutes at room temperature between the second and third washing steps. The

precipitated material was resolved on a SDS PAGE, transferred to a nylon membrane a
exposed to a radiography film (upper panel). Subsequently, the membrane was probed
with anti body against T7 tag (lower panel).

(B) Sequence of the domain encoded by exon H (H domain). The residues colored in red
and numbered 1 to 6 are the phosphorylation sites predicted by Prosite
(http://us.expasy.org/prosite/) and Scansite (http://scansite.mit.edu/).

(C) Identification of the phosphorylation site by site-directed mutagenesis. Metabo

phosphorylation assay was performed as in (A). Expression constructs encoding NovaH+ (lane 1), Nova-1 H- (lane 2), and point mutants in which the indicated residues

mutated to Alanine (lanes 3 to 6) were transfected. The numbers above the lanes ref
the numeration of the phosphorylation sites in Fig. 16B.
(D) Constructs encoding Nova-1 H+ (lane 1), Nova-1 H- (lane 2) and a Nova-1 H+ in
which the Serine of site 2 was mutated to Alanine were utilized for the
transfection/metabolic labeling assay as in (A).
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Figure 16: The state of phosphorylation of site 2 does not affect the properties of
Nova-1 in splicing and localization:

(A) Co-transfection splicing assay of GlyRcx2 minigene in 293 T cells. Increasing a

of DNA constructs encoding Nova-1 H+ and Nova-1 H- were co-transfected with a fixed
amount of vector encoding GlyRa2 minigene. The ratio of the spliced isoforms was
assessed by RT PCR like in figure 2.

(B) The same co-transfection assay was employed by co-transfecting increasing amoun
of vector encoding Nova-1 carrying a mutation of the site 2 either to Alanine or to
Glutamate with GlyRa2 minigene.

(C) Intracellular localization of the two Nova-1 H+ and H- isoforms was assessed by
immunocytochemistry in transfected N2a cells.
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Discussion

W e demonstrated that Nova-1 regulates alternative splicing in several experimental

systems. The analysis of Nova-1-null mutant animals had shown that the splicing of a

candidate target RNA for Nova-1, GlyRa.2 pre-mRNA, was mis-regulated specifically in
the areas of the CNS where Nova-1 is normally expressed. The alternative exon 3A,

which is preceded by an intronic sequence matching the consensus for Nova binding, i

under-utilized in the Nova-null animals. Consistent with this, a reciprocal increase
utilization of exon 3A was observed upon co-transfection of Nova with a GlyRa2
minigene in three different cell lines. The mutation of the candidate Nova-binding
intronic sequence abolished the Nova-dependent effect. Furthermore, we demonstrated

by UV cross-linking and in vitro splicing assay that the effect of Nova on alternat

splicing is at the RNA level. Nova protein from brain extracts specifically cross-li
sequence (UCAUY)3 but not the mutant sequence (UAAUY)3. Purified Nova-1 fusion

protein added to HeLa nuclear extract promotes the splicing of a cassette exon of a
artificial pre-mRNA derived from GABAARy2 pre-mRNA, another gene whose splicing
was found to be mis-regulated in the Nova-null mutants.

Nova-1 was the first described tissue-specific regulator of alternative splicing in

vertebrates (Jensen et al., 2000a). Few other such factors have been described since

A largely brain-restricted protein similar to PTB called brain PTB (brPTB) or neura

(nPTB), was discovered in a search for proteins interacting with Nova and independen

106

biochemically purified (Markovtsov et al., 2000; Polydorides et al., 2000). A family of

six RNA binding proteins called CELF (CUBP and Etr-1-like factors) or Brunol (Brunolike) have been recently described, some of whose members are exclusively expressed

one or two tissues (Ladd et al, 2001; Suzuki et al., 2002). ET3, a member of this fam

increases the splicing of exon 5 of chicken cardiac Troponin by interacting with int
elements called muscle-specific enhancers (MSE) (Charlet et al., 2002; Ladd et al.,

2001). Another member of this family, NAPOR1, is enriched in restricted areas of the
central neural system, and the pattern of splicing of /V-methyl-D-aspartate (NMDA)

receptor pre-mRNA correlates with its distribution. Experiments in transfected cells
a NAPOR1-dependent effect on a NMDA minigene splicing, and identifies particular
intronic elements required for such regulation (Zhang et al., 2002). The RNA-binding

protein Fox-1, whose expression is restricted to brain, heart and skeletal muscle in
vertebrate, has recently been shown to regulate the alternative splicing of several

containing its binding sequence UGCAUG (Jin et al, 2003). A few other tissue-restrict

splicing regulators have been identified in invertebrates, for instance the neural-s

ELAV as well as the ovarian-specific Half Pint in Drosophila (Koushika et al., 1996;
Koushika et al., 2000; Lisbin et al., 2001; Van Buskirk and Schupbach, 2002).
The first well-characterized cascade of regulated alternative splicing, the sex
determination pathway in Drosophila, consists of a series of binary choices between
regulated and a default pathway. Female-specific factors (Sex-lethal, Transformer)

instruct the regulated, female-specific pattern of splicing; in absence of such fact
pre-mRNAs are processed along the male-specific pathway, apparently the default

pattern (reviewed by Wang et al., 1997). The observation that the tissue-specific exo
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vertebrate are most often poor splice substrates because of their small size and poor
match to the consensus splice sequences prompted the idea that for vertebrates the

skipping in the inappropriate cell types is also a default pathway (Black, 1991; Dom
and Kole, 1991; Dominski and Kole, 1992; Xu et al., 1993). The discovery of the

antagonistic effects of ASF/SF2 and hnRNPAl on the 5' splice site choice (Mayeda an

Krainer, 1992) revealed a general feature of alternative splicing regulation in vert
the choice between alternative pathways of splicing is the result of the interplay

activating and inhibiting factors. Most of the studied cell-type specific events hav

revealed complex mechanisms in which activating factors not only promote splicing, b

also counteract inhibitory mechanisms. For example, in the case of the exon Nl of c

splicing, one of the best-characterized instances of tissue-specific alternative spl
several activators have been identified. KSRP, hnRNP H and hnRNP F promote the
inclusion of exon Nl by binding the Downstream Control Sequence (DCS), while

ASF/SF2 exerts its activating role interacting with the exon itself. These activator

required not only to overcome the intrinsic weakness of exon Nl, but also to counte

the inhibitory role of PTB, which binds on both sides of the alternative exon, possi
forming a RNA looping complex that masks exon Nl to the splicing machinery

(reviewed in Black, 2003). brPTB (or nPTB) is a weaker inhibitor of the inclusion of

exon Nl in vitro than PTB thus providing a possible mechanism for the tissue specif

of exon Nl inclusion (Markovtsov et al, 2000). Analogously, the inclusion of exon 5 o
cardiac Troponin (cTNT) is controlled by a balance of the positive action of ETR-3
member of the CELF family- and the inhibitory action of PTB. The proportion of exon

inclusion doubles when fibroblasts are transfected with a dominant negative form of
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P T B , and returns to baseline when a dominant negative form of C E L F is co-transfected

(Charlet et al., 2002). The data on Nova-1 co-transfection with brPTB suggest a simi

scenario, at least in the case of regulation of alternative splicing of GlyRa2, wher

antagonizes the effect of Nova (Polydorides et al., 2000). While we have not yet test
the effect of co-transfection of PTB or brPTB on the Nova-dependent activation of

GABAARy2 splicing, previous studies have demonstrated an inhibitory effect of PTB on

the splicing of this substrate (Ashiya and Grabowski, 1997). The interactions of Nova
with U2AF65 and Ul 70K suggest that Nova can also regulate alternative splicing

through a direct effect on recruitment of the spliceosome (Fig. 17A). In the case o
regulation of GABA yr2 pre-mRNA splicing by Nova, one can hypothesize that the

interaction with Ul 70K is instrumental to recruit the entire Ul snRNP to the 5' sp

most proximal to the intronic Nova binding site. TIA1, a splicing activator acting t

an intronic enhancer, has been shown by psoralen-mediated UV cross-linking assays to

increase the recruitment of Ul snRNP to a weak 5'splice site through its interactio
Ul-C (Forch et al., 2000; Forch et al., 2002). Future in vitro studies will employ a
approach to verify a similar effect on Ul recruitment by Nova through Ul 70K.

Some features of the Nova-1-null mutants, like tremors and motor dysfunctions

are consistent with functional failure of inhibitory responses in the CNS, as one w
expect from impairment of the Glycinergic and GABAergic pathways. Several
observations show that the GABAARy2 subunit is a very important component of the
GABAA receptor. Mutations of the GABAARy2 subunit have been documented in

association with various forms of familial epilepsy (Baulac et al., 2001; Bianchi e
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2002; Bowser et al, 2002; Harkin et al, 2002; Marini et al., 2003; Wallace et al., 2001).

The targeted disruption of the entire GABAARy2 subunit in mice results in animals t

are normal at birth, but subsequently show retarded growth, sensor-motor dysfunction

and reduced life span. Consistent with previous studies identifying GABAARy2 subunit

the target of benzodiazepines, the mutant mice are insensitive to this family of dru
(Gunther et al., 1995). However, present knowledge concerning the differences in

physiologic proprieties of GABAARy2L and S isoforms does not provide a satisfactory

explanation for the dramatic phenotype of Nova-1-null mutant mice. The alternative e

9 of GABAARy2 encodes a stretch of eight amino acids that are thought to contribute

the intracellular loop between the third and the fourth putative transmembrane doma
GABAARy2 (Pritchett et al., 1989). Mice resulting from the specific deletion of the

alternative exon 9 show only slightly altered responses in tests designed to measur

level of anxiety, and higher sensitivity to benzodiazepines compared to their wild t
littermates (Homanics et al., 1999; Quinlan et al., 2000). Even less is known about

features of the two isoforms of GlyRa2 generated by the inclusion of exon 3 A or 3B

two exons encode twenty-three aminoacid long extracellular domains that differ by o

two amino acids (Kuhse et al., 1991), and no functional differences have been descri
It is probable that the phenotype of Nova-1-null mice results from defects of the
regulation of other genes at the level of splicing beside GlyRa2 and GABAARy2, and
possibly, given the high degree of integration of the mechanism of gene expression,

level of export, localization of the messages and translation. Cytoplasmic and dendr
distribution of Nova has indeed been demonstrated by immunocytochemistry both in

cultures of primary neurons and in ventral horn spinal cord neurons (Triller and Dar
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unpublished). T o gain some insight in the function of the cytoplasmic Nova, w e began

the characterization of the cytoplasmic structures Nova interacts with, by analyzing

cytoplasmic extracts in linear density gradients. Rather large cytoplasmic structure
sedimenting around 80S, are observed in extracts of animals from P3 to P30. Unlike

translating polysomes, these structures are resistant to treatment with high concent

of EDTA. We are inclined to consider these structures mRNPs, similar to structures o

similar size characterized as reactive to antibodies against FMRP, Hu and ctCP (Anti

and Keene, 1998; Feng et al., 1997; Ji et al., 2003). Further experiments are require

unambiguously establish the nature of these structures. Poly(A) specific fractionati

Chromatography on OHgo(dT)-cellulose (Dreyfuss et al., 1984a; Dreyfuss et al., 1984b

and a more stringent treatment with RNAse will verify their RNA content. An amount o

Nova that increases with age, up to around twenty-five percent at P30, sediments in

denser fractions of the gradient, and shifts to the upper part of the gradient in pr
EDTA, a behavior consistent with association with polysomes.
In an attempt to achieve a broader picture of the changes in gene expression levels

underlying the phenotype of the Nova-null mutants, we utilized the RNA purified from

the polysomal fractions of the gradient to interrogate DNA microarray. We compared t

information obtained with the levels of gene expression in the input material. The o

number of sequences that show variations between wild type and mutants is rather sm

compared to the variations observed comparing polysome fractions from lymphoblastoi

cell lines expressing normal or non-functional FMRP (Brown et al., 2001). As in Brow

et al., 2001, we observed both increased and decreased abundance of specific messag

the polysomal fraction. Little information is available about the biological proprie
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quite large portion of the sequences that show modified levels in polysomes in Nova-null

mice. At least six sequences have known biological proprieties that can be related t

role in growth cone functions, post-synaptic architecture and related signaling path
Two of them are increased and four decreased in absence of Nova, exclusively in the
polysome fraction. We also found three metalloproteases to be decreased in the
polysome-associated pool of mRNAs in absence of Nova. Metalloproteases have a

demonstrated role in neurites growth during development of the CNS, among many other
functions (reviewed in (McFarlane, 2003; Yong et al., 2001).
While the decreased levels of these messages in the polysomes purified from

Nova-1-null mice is consistent with a positive role of Nova-1 in the regulation of t

translation, many issues remain open for future investigation. The data obtained fro
microarrays only provide a picture of the final outcome of potentially many events
consequent to the absence of Nova-1. Although the decreased level of messages

exclusively in the polysomes hint at a role of Nova in translational regulation, the

modality of such action is unclear. One first point to be addressed is the validatio

consistent changes in the level of the proteins encoded by the messages whose abunda
is altered. Another important question is whether the altered level of messages are
a direct effect of Nova through interaction with the proposed target RNAs. Although
of potential Nova binding sites are identifiable by inspection of the sequences, no
evidence of a physical interaction is presently available.
Most of the described mechanisms of translational regulation by RNA binding

proteins in eukaryotes involve an inhibitory effect that is removed upon the deliver

appropriate signal. Among the best studied examples, hnRNP K, El and E2 are known to
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inhibit the initiation of translation of 15 L O X m R N A by binding the 3'UTR (Ostareck et

al., 2001; Ostareck et al., 1997). Iron regulatory proteins (IRP) regulate translatio

ferritin by inhibiting initiation through an interaction with the 5' UTR of the mess
upon increase of the Iron levels which are bound by IRP, a conformational change of
proteins induces the release of the inhibition (reviewed in (Hentze and Kuhn, 1996).

Nova could conceivably inhibit translation with analogous mechanisms at the level of

initiation. On the contrary, the decreased levels of mRNAs in the Nova-null polysome
suggest a positive effect of Nova on their translation. While mechanisms of general
activation of cap dependent translation through mTOR protein kinase are well
characterized, few examples of translational activation of subset of messages by
sequence-specific RNA binding proteins are known. In Drosophila, Aubergine has been
shown to enhance oskar translation in the ovary (Wilson et al., 1996). Motifs with

translational enhancer activity have been identified in plants (Yamamoto et al., 199

The RNA-trafficking sequence (RTS) originally identified as a determinant for transp
of Myelin Basic Protein (MBP) mRNA is a vertebrate translational enhancer. hnRNP A2
acts on RTS as a trans-activator (Kwon et al., 1999). The finding of simultaneous

increase of some messages and decrease of others in the polysome fraction in respons

the abolition of Nova is seemingly paradoxical. Nonetheless, translational control f

seem to act in a combinatorial fashion in many instances. Analogous to well-document

principles of transcriptional regulation, distinct protein-protein interactions betw
binding proteins are thought to discriminate among various RNA substrates and yield
specific biological outcomes (reviewed by Wickens, M., et al., 2000). HnRNP El acts

with hnRNP K to repress 15 LOX translation, by binding the DICE element (Ostareck et
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al., 1997), but it has additional roles as well. In fact, H n R N P El with h n R N P E2 is also
part of the a-complex that promote the stability of a-globin mRNA by binding to CU-

rich sequences in the 3'UTR, ultimately promoting the expression of this gene (Kile
et al., 1995; Wang et al., 1995). Therefore, by interacting with two different mRNAs

part of two different protein complexes, hnRNP El exerts two opposite effects on the
expression of two different genes in the same cell type. Furthermore, the mRNAs
analyzed on microarrays were purified from spinal cord, which is constituted by a
heterogeneous population of neuronal subtypes: inhibitory and activating actions of

on translation could conceivably not take place simultaneously in the same cell. Giv
the similar sedimentation pattern on linear density gradient, and the demonstrated
physical interaction, Hu proteins are possible functional partners of Nova in the

formation of complexes with a positive role on translation. Increased translation of
neurofilament M mRNA has been described in response to over-expression of HuB, in

absence of stabilization of the message (Antic et al., 1999). The translation of a nu

of other messages has been shown to be increased in response to Hu proteins, but the
mechanism of such effect is not known (Keene, 2001).
A noticeable feature of the mechanisms of translational control in early

Drosophila and C.elegans development is the strict coordination of mRNA localizatio

and translation (Johnstone and Lasko, 2001). In several instances, the translation of
particular mRNAs in an inappropriate location in the cell could have damaging

consequences; therefore mRNA is complexed with proteins that keep it masked from the
translational apparatus during transport and mediate interactions with cytoskeleton
motor proteins. One possible interpretation of the observed decrease of certain RNA
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the polysomes of Nova-1-null animals is the loss of a hypothetical localizing effect. One
could envisage a scenario where in absence of Nova its mRNA targets do not reach a

location in the cell where they are usually translated. If, in order to be translate
mRNAs are required to be localized in the dendrites or in the growth cone, and the
absence of Nova impaired such spatial targeting, one would expect a diminished
engagement in the polysomes in the Nova-null mice. An obvious implication of this
model is that the mRNAs that we found decreased in the polysomes should be normally
localized in discrete domains of the cytoplasm.
The observation of splicing defects and translational alterations in the Nova-null
mutants makes it tempting to consider a direct connection between the nuclear and

cytoplasmic events regulated by Nova-1. However, we have not observed alterations of
the polysome distribution of GABAR and GlyR mRNA in absence of Nova. The

knowledge of translational alteration in Nova-null mutants puts us in the position t

tackle the hypothesis of coupling between the nuclear and cytoplasmic events regulat

by Nova from the cytoplasmic end of the mRNA's journey. If that is the case, one wou
expect changes in the pattern of alternative splicing of those mRNAs whose level is

altered in the polysomes. Recent investigations conducted in our laboratory have led

the isolation of a number of RNAs based on their physical association with Nova. The

splicing of some of these new targets is modified in absence of Nova (Ule and Jensen

unpublished). Interestingly, a number of them encode proteins involved in clustering
receptors, post-synaptic structures and growth cones, similar to the mRNAs we have
found altered in the polysomes. However, no overlapping RNAs between the two
screenings have emerged at present. The data emerging from diverse approaches are
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beginning to draw a rather complex picture of the functional role of Nova in the

regulation of gene expression. We have shown that Nova affects the pattern of altern
splicing of an as yet unknown number of genes, and we provide initial observations

suggesting a role in the regulation of cytoplasmic events of gene expression (Fig. 1

Functionally related genes encoding receptors, components of the post-synaptic densi

growth cones and elements of related signal transduction pathways are regulated by N
at different steps of their expression pathway.
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Figure 17: Functions of N o v a in R N A metabolism:
(A) Nova acts in the nucleus as a regulator of alternative splicing. Our data suggest that
Nova binds to intronic enhancers and promotes the utilization of the most proximal splice
sites of the intron it is bound to. This observations and the interactions with Ul 70K and
U2AF65 suggest that Nova recruits components of the basic splicing machinery to the
closest splice sites.
(B) Changes in the relative abundance of messengers specifically in the polysome
fraction in absence of Nova-1 suggest that the pehnotype of Nova-1-null mice is at least
partially imputable to alterations of gene expression at the level of translation. Since
Nova has been observed in discrete foci in the dendrites, coincident with reactivity for
component of the ribosome, one can speculate a functional role in regulation of peculiar
aspect of translation in neurons, like coupling of translation to neural activity in
phenomena of synaptic plasticity. Consistently with this hypothesis, several messengers
whose association with polysomes is altered in absence of Nova-1 encode proteins with
functions related to the maturation or function of synaptic contacts.
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